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Abstract 
Diagnosis, monitoring and curing of various vascular abnormalities can be 
linked to measurements of wall thicknesses of blood vessels. However, use of echo 
ultrasonic signals for these measurement is complicated by the low level of 
reflections from the vessels (1-2% from the incident energy), which results in 
considerable noise. Since the changes in thickness to be monitored are very small, 
this requires operation of ultrasonic scanners at high sampling frequencies, much 
higher than 50±100 MHz sampling frequencies that are used by contemporary 
ultrasonic scanners. That is because the resolution of the measured thickness is 
dependent on the time domain resolution of the recorded echoes; the latter is 
determined by the sampling frequency. An additional issue is the variability in the 
blood vessel wall thickness depending on the phase of the heart activity. Several 
studies show that these variations with a cycle time of around one second result in 
the same changes as building atherosclerosis for one year. 
The objective of the study was to develop an instrument that would allows 
recording of ultrasonic A-scans that are synchronised with the heart activity and that 
would allow improved accuracy of wall thickness measurements. Using an 
electronics point of view, the objective was met by the simulation, construction, 
programming and testing of an ECG monitor that triggers ultrasonic scans. The 
FPGA design of an existing high accuracy ultrasonic A-mode scanner was modified 
to allow interfacing of this monitor. Ultrasonic scans were taken with different 
WUDQVGXFHUV DQG WUDQVGXFHU DWWDFKPHQWV ³VKRHV´ XVLQJ YDULRXV VHWWLQJV RI WKH
scanner. The scans were then analysed using dedicated Matlab programs. 
Overall, the design proved to be successful ± it allowed repeatable records to be 
obtained at the same stage of heart activity. However, reliable and unambiguous 
detection of the artery walls (especially the back wall) was achieved only 
sporadically within the time available for in vivo experiments. 
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Chapter 1 - Introduction 
 
1.1 Ultrasonic medical imaging 
Ultrasound is an imaging technique that uses high pitched inaudible sound 
frequencies. These frequencies are generated and transmitted to obtain 
reflections from a structure in order to give an internal view of it. Many 
different applications today use ultrasound, ranging from industrial to 
chemical and medical uses. The approximate frequency ranges corresponding 
to ultrasound, and the applications related to the frequencies being used are 
shown in fig 1.1: 
 
Figure 1.1: Diagram showing the applications of various ultrasound 
frequencies [1.1] 
The non-destructive evaluation (NDE) is used to find flaws in order to 
assess the quality of a component during the manufacturing process, or to 
service an operational object to find if there are any cracks due to intense use. 
These types of tests are common in various industrial companies. The 
frequencies used for these applications typically range from 2 to 10 MHz, but 
lower frequencies are also used to examine less dense materials such wood 
and concrete. In contrast, medical ultrasonic applications usually use 
frequencies ranging from 2 to 20 MHz, where the operating frequency would 
depend on the body part being diagnosed. The most common applications of 
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medical sonography are related to obstetrics. However, medical sonography is 
used in many other medical departments such as Cardiology, Endocrinology, 
Gastroenterology, Gynaecology, Ophthalmology, Urology, Vascular, 
Intravascular, Biopsy and Histology. Typical scans provide images of the 
heart, liver, muscles, eye, gallbladder, arteries, veins, fine needle aspirations, 
masses and lymph nodes. The UK Department of Health estimates that the 
number of non-obstetric medical sonography scans accounts for 65% of the 
total number of ultrasonic scans taken [1.2]. Although many other types of 
medical imaging are available for the assessment of different parts of the 
body, such as Magnetic Resonance Imaging (MRI), nuclear medicine or a 
Computed Axial Tomography (CAT), ultrasound medical imaging is 
preferred in many cases (fig 1.2). 
Advantages Disadvantages 
- It offers a real time imaging where the 
sonographer can select the most important areas for 
diagnosing and can keep a copy. 
- Ultrasound is not powerful enough to go 
through bones 
- It can be used for many different applications 
since it shows the structures of organs, which makes it 
very flexible 
- Unlike CAT and MRI scans there is no 
scout imaging so it is harder to determine the 
desired area. 
- Compared to the other types of imaging, it is 
less expensive. The instrument is also smaller and 
portable.  
-Accuracy depends on the experience and 
skills of the sonographer: an accurate image 
requires a highly experienced sonographer 
- No known long term side effects or any 
discomfort caused to the patient 
- The penetration depth is limited and it 
could be harder to image patients who are obese. 
Figure 1.2: Advantages and disadvantages of ultrasound imaging in 
medicine 
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An important advantage of the ultrasonic scans, shown in fig 1.2, is the 
absence of any known long-term side effects. In the medical field, ultrasound 
is considered not to present any risks to the patient [1.3] and is called a safe 
test since the patient is not exposed to harmful radiation. However, some 
physiological effects are possible, such as inflamed sensations, heating of soft 
tissues [1.4], or cavitation in human body liquids exposed to intense 
ultrasound radiation. The long-term effects of these factors are not yet known 
[1.5]. Nevertheless, medical ultrasonography is used as a check-up to detect 
any abnormal conditions that would put either the mother or the baby at risk 
during pregnancy. Medical experts would rather take the risks resulting from t 
possible harm produced by ultrasonic radiation in order to identify any 
abnormal conditions [1.6]. 
Ultrasound is also used for therapy, treatment and hygiene. In physical 
therapy (therapeutic ultrasound), ultrasound with frequencies 1 ± 3 MHz is 
used to create waves with high water or low protein content. These waves 
then bounce off bone and cartilage, as these waves are absorbed mostly by the 
connective tissue: ligaments, tendons and fascia [1.7]. This speeds up the 
healing process of injured muscle tissues and joints. 
Ultrasound used in drug delivery applications is termed Acoustic Targeted 
Drug Delivery [1.8]. The frequencies used for these applications are within 1 
± 10 MHz. This method is mostly used in cancer treatments, such as tumour 
treatment. When a tumour is removed by surgical methods, first of all the 
drug±encapsulated wafer needs some time to react. Due to the complications 
that exist while removing the tumour cells in surgery [1.9], Acoustic Targeted 
Drug Delivery can help in speedy delivery of the drug, resulting in a decrease 
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in the time needed for it to react [1.10]. This method has been applied 
successfully in chemotherapy where its application reduced both time and 
risk. This method was also found more efficient for treatment of infected 
areas [1.11]. 
Both therapy and treatment fall under the same procedures, termed 
Therapeutic Ultrasound and include a number of different treatments [1.12]. 
Ultrasound in the range 20 - 40 kHz can also be used for hygienic purposes 
with dental and surgical instruments, eliminating dirt by mechanically 
breaking it off of surfaces. Ultrasound is also used for the elimination of 
bacteria for medical and industrial purposes, as a way of disinfecting waste 
undergoing disposal. 
This project will focus on ultrasonic medical imaging. The inaudible 
sound waves are created at frequencies greater than 20 kHz by mechanical 
oscillations of piezoelectric crystals. These waves can be focused using an 
acoustic lens and by changing the signals applied to the ultrasonic 
transmitters. This focusing helps to improve both axial and radial resolution. 
Different types of transducers include linear, curvilinear and phased array 
transducers. All of these will have different uses because not every part of the 
body is easily accessible using any single type of transducer.  
Newer technology uses phased arrays while the older ones used an 
acoustic lens to focus the wave being sent. A water-based gel is used as an 
interface between the transducer and the body, because most of the energy 
would be reflected back to the transducer if no acoustic impedance-matching 
was used. After propagating a water-based gel, the waves travel through 
different objects of the body and are reflected back at the interfaces between 
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objects with different acoustic impedances. The receiver of the ultrasonic 
waves converts these reflected waves into electrical signals. In the pulse-echo 
mode, the same transducer is used first for transmission, then for reception. 
The ultrasonic instrument determines the wave propagation time and the 
amplitude of the reflected waves. This information is then plotted on a 
display, with different colours assigned to different amplitudes. Usually a 
greyscale imaging is used for amplitudes of the reflected waves, but some 
newer technologies use colour imaging. 
 
 
 
 
 
 
Figure 1.3: Classification of medical ultrasonic imaging 
 
Fig.1.3 presents four distinctive types of medical ultrasonography: 
 
Fig 1.4: A-mode ultrasonic scan [1.13] 
M-mode 
Ultrasound 
A- mode B-mode Doppler 
Pulsed-wave Pulsed-wave Continuous 
wave 
Pulsed-wave 
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A-mode: This is the most basic type of ultrasonic scanning. Its basic 
principle is a single transducer that is placed on the body and the waveform 
from the transducer then forms an image on the screen. Fig.1.4 shows 
reflections at points A and B. Time delay between these two points can be 
converted into the distance in that medium, using ultrasonic velocity. 
  
 
Figure 1.5: B-mode ultrasonic scan [1.14] 
 
B-mode: B-mode is not appreciably different from the A-mode, since in 
the B-mode an array of transducers is used to scan a specific area of the body. 
This can then be viewed as a 2D-image (fig.1.5). The B-scan is, in fact, a 
number of A-scans combined and plotted onto the screen, thus making this 
scan easier to analyse. B-mode scans are the predominantly form used for 
medical imaging at present. 
Doppler: There are two further subdivisions of this method: continuous 
and pulsed wave. Continuous wave (CW) usually takes into account the phase 
shift between the transmitted and received waves, whereas the delay between 
the transmitted and received pulses is of interest in the pulsed wave method. 
Doppler ultrasound helps to determine blood flow velocity and its direction. 
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Figure 1.6: CW Doppler ultrasound scan for detection of aortic stenosis 
and insufficiency [1.15] 
Two piezoelectric elements (the transmitter and receiver) operate 
continuously in the Doppler CW mode. The advantage of this mode is that it 
can detect very high flow velocities, as is seen in the lower portion of fig.1.6. 
The disadvantage of this method is the difficulty in detecting of the point of 
origin. An ECG is frequently superimposed onto the Doppler CW scans (as 
indicated in fig. 1.6) to identify what is happening at any point in the cardiac 
cycle. 
 
Figure 1.7: Diagram showing the Common Carotid Artery on a pulsed 
wave (PW) Doppler ultrasound [1.16] 
For a pulsed wave (PW) the same piezoelectric element is used for 
transmitting and receiving. The common carotid artery (CCA) can be seen at 
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the top of the diagram fig.1.7 where a PW gate is shown. The sonographer 
can control the gate (making it larger or smaller, or even lower or higher) to 
view the point of interest. The PW Doppler scan shows the direction and 
velocity of the flow (lower portion of fig.1.7). The direction of the flow can 
also be identified by considering the gate colour. Pulse waves are used more 
frequently than are continuous waves in contemporary medical ultrasound 
imaging. 
 
Figure 1.8: Cardiac M-mode ultrasound [1.17] 
M-mode: Just as B-mode is formed from a combination of A-mode scans, 
the M-mode is formed from a combination of B-scans taken one after another 
and updated quickly on the screen. M-mode allows sonographers to see 
movement over time (it is called M-mode because it shows motion), and the 
parameters of the motion can be measured as necessary. At first, a B-mode 
scan is taken, as shown in the upper portion of fig.1.8. The sonographer then 
chooses the line of interest on the B-mode scan as shown in the upper part of 
fig.1.8. Once the line of interest is chosen, the system will show the structures 
either moving to or away relative to that line (fig.1.8). The ECG signal is 
frequently superimposed underneath the scan to allow the sonographer to 
relate the scan to the heart activity. 
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1.2) Vascular medicine and atherosclerosis 
The prevalence of diabetes mellitus is increasing worldwide due to 
sedentary life quality, obesity and diet habits. Consequently, the 
complications of diabetes, especially atherosclerosis, are increasing. 
Detection of early signs of atherosclerosis is crucial for reducing cerebro-
vascular accidents and hence for providing patients with early stage medical 
and/or surgical treatment, if necessary. 
The main method for the early detection of atherosclerosis in diabetic 
patients is the measurement of intima media thickness (IMT) of the artery 
wall. If atherosclerotic disease is detected early in diabetic patients, further 
development of carotid stenosis and stroke can be prevented. 
The human body consists of many different blood vessels that form from 
arteries and veins, as shown in figure 1.9. Blood flow through each of these 
blood vessels is different and will depend on the age of the person [1.18]. 
 
Figure 1.9: Diagram showing the arteries and veins in a human body 
[1.20] with the intima media thickness (IMT) annotated 
IMT 
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Eight different arterial lesion types [1.19] occur, which can be divided 
into two groups (fig 1.10): early stage lesions 1-3 and advanced lesions (4-8). 
 
 
 
 
 
 
 
Figure 1.10: The developmental stages of arterial lesions [1.21] 
 
As the lesion progresses, the wall thickness increases and the lumen 
cross-sectional area narrows. Early lesions and even advanced lesions can be 
clinically silent until a heart attack. The risk for lesion development depends 
on both modifiable and non-modifiable factors. Non-modifiable risk factors 
include those such as age, gender, genetic factors, race and environment that 
cannot be corrected. In contrast, the modifiable risk factors that include 
smoking, high blood pressure, stress, obesity, diabetes mellitus and physical 
inactivity can be influenced by changing eating habits, by exercising and by 
undergoing medical treatment. 
While guidelines for detection of silent myocardial and lower limb 
ischemia are well established, data on screening asymptomatic carotid lesions 
remain scarce. The ADA (American Diabetes Association) [1.22] 
recommendations for detection of silent myocardial ischemia agree on the 
following criteria: age and presence of another macroangiopathic disease as 
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two additional cardiovascular risk factors (CVRF). They disagree, however, 
on two other criteria, namely duration and type of diabetes. The 
SFC/ALFEDIAM (French Cardiology Society/French-speaking Association 
for the Study of Diabetes and Metabolic Diseases) [1.23] recommends carotid 
ultrasonography screening for patients with myocardial or lower limb 
DWKHURVFOHURVLV DQG IRU SDWLHQWV ZKRVH FDUGLRYDVFXODU ULVN LV ³SDUWLFXODUO\
KLJK´'LDEHWLFSDWLHQWVDUHVXEMHFWWRDQ LQFUHDVHGULVNRI LVFKHPLFFHUHEUDO
attack. According to a recent SFC report [1.24], the risk in diabetic patients is 
two to five times higher than that in the general population. (For the general 
population, the prevalence is 1 per thousand patients [1.27].) In studies that 
include diabetic patients without known macroangiopathy, the increased risk 
was even higher, at over 6.2 per thousand patients according to the 
Collaborative Atorvastatin Diabetes Study (CARDS) [1.25] or 5 per thousand 
patients according to the UK Prospective Diabetes Study (UKPDS) [1.26]. In 
addition to the classical CVRFs, several predictive factors for ischemic 
cerebral attacks were identified in [1.28], namely triglyceride levels, blood 
sugar and HbA1c.  
The outcome of these strokes differs between diabetic and non-diabetic 
patients: the diabetic patients are more handicapped, particularly by lower 
limb deficits and dysarthria [1.29]. Therefore, the detection of carotid lesions 
in diabetic patients is even more important for improving life expectancy and 
quality of life. However, this type of screening would be costly, since the 
prevalence of diabetes is constantly increasing worldwide. Therefore it is 
necessary to establish criteria that can define the category of patients who are 
particularly at risk of ischemic cerebral attack as well as those who would 
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hopefully benefit from medical or surgical management with the aid of this 
development.  
Reduction of the costs of ultrasonic scanners would directly reduce the 
screening costs. The cost of screening would be reasonable if the relative risk 
reduction provided by screening is 37% or more and if the cost of ultrasound 
screening is less than $300 [1.30]. According to Whitty et al [1.31], screening 
for asymptomatic carotid stenosis would be beneficial only when the 
prevalence of severe stenosis is more than 20%. According to Derdeyn [1.32] 
(in a study mostly on secondary prevention), in patients with more than 20% 
prevalence of a 60%-stenosis, a one-time screening program is most cost-
effective. Yin [1.30] recommends one-time screening, which is superior to 5 
yearly screenings, considering quality of life and cost. In asymptomatic 
patients undergoing currently recommended therapy [1.33], the natural 
progression of median carotid stenosis shows no changes within 4 years. 
Therefore, it is unnecessary to repeat investigations when optimal medical 
care is applied. 
Carotid IMT was initially reported to increase the relative risk (RR) of 
cardiovascular disease [1.34] in a non-diabetic population. Bernard et al 
[1.35] studied patients with type 2 diabetes mellitus (T2DM) and with at least 
1 additional CVRF. They concluded that carotid IMT was a marker of 
cardiovascular risk in 5 years. According to Hayashi et al [1.36], 
measurement of the carotid IMT was a reliable prognostic indicator of heart 
attack, cerebral stroke or carotid atheroma in T2 diabetes patients. IMT 
measurements, which are reliable and reproducible, are also correlated with 
the results of myocardial scintigraphy in patients screened for silent 
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myocardial ischemia [1.37]. In type 2 diabetic patients, duration of diabetes 
[1.38], age and smoking duration [1.39], early nephropathy [1.40] and renal 
failure [1.41], cardiac neuropathy [1.42], and even post-prandial 
hypertriglyceridemia [1.43] appear to increase the IMT. Nagata et al [1.44] 
suggested type 2 diabetes to be a major risk factor of cerebral lacunas and 
carotid arterial plaque, independent of hypertension. De Angelis et al [1.45] 
studied the prevalence of carotid stenosis in cerebrovascular disease-free type 
2 diabetic patients. Diabetic patients were three times more likely to develop 
carotid stenosis than the non-diabetics. Decades of silent arterial wall 
alterations precede vascular clinical events, which then reflect advanced 
atherosclerotic disease. 
The first morphological abnormalities of arterial walls can be visualized 
by B-mode ultrasonography. This high-resolution, non-invasive technique is 
one of the best methods for the detection of early stages of atherosclerotic 
disease, because it is rapidly applicable, readily available and demonstrates 
the wall structure with better resolution than any other similar technique (e.g., 
magnetic resonance imaging, such as including the adventitia in the IMT 
results, as shown in fig. 1.11) [1.46]. 
 
Fig 1.11: Diagram showing IMT calculation of CCA using MRI [1.47] 
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This is because the IMT reflects not only early atherosclerosis, but also 
nonatherosclerotic compensatory enlargement with largely medial 
hypertrophy as a consequence of smooth muscle cell hyperplasia and 
fibrocellular hypertrophy. This differentiation is important because 
epidemiological studies have shown that wall thickening, as depicted by 
ultrasonographic measurements of IMT, are different from atherosclerotic 
plaque in terms of localization, natural history, risk factors and predictive 
value for vascular events [1.46]. 
The Mannheim Carotid Intima-Media Thickness Consensus (2004±2006) 
recommends the following definitions for ultrasound characterization of IMT 
and atherosclerotic plaque:  
1) The IMT is a double-line pattern visualized by echotomography on 
both walls of the CCAs in a longitudinal image. It is formed by two parallel 
lines, which consist of the leading edges of two anatomical boundaries: the 
lumen- intima and media-adventitia interfaces. The IMT can be seen in figure 
1.4; 
2) Plaque is a focal structure encroaching into the arterial lumen of at least 
0.5 mm or 50% of the surrounding IMT value. 
 
These definitions allow classification of the vast majority of carotid 
lesions observed with ultrasound. Carotid examination includes visualization 
of common, internal and external carotid arteries (CCA, ICA and ECA 
respectively). The CCA can be assessed in nearly every patient. In contrast, 
successful examination of the internal carotid artery and of the carotid bulb 
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depends both upon the anatomical topography of the patient and on the 
VRQRJUDSKHU¶VH[SHUWLVH 
The following observations are related to the IMT measurements:  
1) Measurement of IMT is most convenient in a region free of plaque, 
where the double-line pattern is observed. In this region, the measurements 
are easier to perform, are more accurate, are reproducible and can be 
standardized by computerized analyses. 
2) IMT can be measured in the CCA, at the bulb and at the origin of the 
internal carotid artery. 
3) The IMT values obtained from different sites of the carotid arteries 
should be documented separately [1.46]. 
 
Standard equipment for IMT measurements includes a high-resolution B-
mode system operating preferentially with linear ultrasonic transducers at a 
frequency of about 7 MHz. Appropriate depth of focus (e.g., 30±40 mm), an 
optimal frame rate of 25 Hz (or at least greater than 15 Hz) and appropriate 
gain settings (that introduce minimal intraluminal artefacts) are recommended 
to obtain the best image quality. Logarithmic gain compensation should be 
around 60 dB deep. It must be adjusted to obtain a symmetrical brightness on 
near and far walls, decreasing, if necessary, the gain in the middle part of the 
waveform to avoid intraluminal artefacts.  
Carotid IMT scanning and reading protocol recommendations (European 
Society of Cardiology Guidelines) [1.46] are as follows: 
- The arterial wall segments should be assessed in a longitudinal view, 
strictly perpendicular to the ultrasound beam, with both walls clearly 
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visualized in order to achieve diameter measurements. Lateral probe 
incidence is recommended as it offers the best view in the middle field, where 
the resolution is known to be greater than in the near or far field. A horizontal 
display of the arterial image is also recommended to obtain the optimal 
interfaces between blood and vascular structures, on the longest possible 
segment. The localization of the end of the CCA is necessary to help in 
repositioning during the follow-up; 
- IMT should be measured preferably on the far wall. This is because the 
IMT values from the near wall depend in part on gain settings and are less 
reliable. If taken on the near wall, IMT should be measured separately from 
IMT of the far wall; 
- Along a minimum of 10 mm length of an arterial segment, a high-
quality image acquisition is required for serial reproducible measurements. 
Due to vessel tortuosity, IMT measurement could only be possible at a shorter 
vessel segment, especially in the carotid bifurcation or the ICA bulb; 
- Adventitia-to-adventitia diameter and intraluminal diameter of CCA 
must also be measured, as IMT is significantly correlated with the arterial 
diameter; 
- Each vascular laboratory must perform periodical quality control of their 
equipment (phantom scans) and reliability studies of scans and measurements 
for ultrasonographers and readers. The intraclass correlation coefficient 
should be evaluated for intra- and interobserver variability, both for IMT and 
plaque measurements. 
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The available epidemiological data indicate that increased IMT (at or 
above 1 mm) represents a risk of myocardial infarction and/or 
cerebrovascular disease [1.48]. 
The presence of increased carotid IMT in one individual with 
intermediate cardiovascular risk would be expected to lead to his 
classification into the high-risk category and thus would influence the 
aggressiveness of risk factor modifications [1.48]. Various non-invasive 
markers of early arterial wall alteration are currently available, such as 
arterial wall thickening and stiffening, endothelial dysfunction and coronary 
artery calcification [1.49]. Among these, the IMT of large artery walls, 
especially the carotid, can be assessed by B-mode ultrasound in a relatively 
simple way and this measure is safe, inexpensive, precise and reproducible 
[1.50]. However, the measurement of IMT in the distal common carotid 
artery suffers from the inability to assess whether IMT represents 
atherosclerosis (intimal thickening) or vascular hypertrophy (medial 
thickening), or both. The reason is that ultrasonography cannot distinguish 
between intimal thickness and medial thickness in the IMT measurement 
because of insufficient axial resolution. Therefore, the IMT, when measured 
in the distal common carotid artery, free from intrusive atherosclerotic 
plaque, should be considered as a marker of early arterial wall change rather 
than as a surrogate for atherosclerosis [1.48]. The type of reading of the IMT 
value (i.e., automatic versus manual) also influences reproducibility. The 
automatic measurement clearly has better reproducibility than operator-
dependent manual measurement [1.48]. 
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Since the IMT is now increasingly used for detecting early alterations of 
the arterial walls, it is of major clinical relevance to define the threshold 
values beyond which the IMT may be considered as abnormally high. Thus, 
ultrasonographic diagnosis of ³LQFUHDVHG´ ,07 LQ RQH LQGLYLGXDO DW ULVN IRU
atherosclerosis might help to better stratify the risk of the patient [1.51].  
7KH ³QRUPDO´ YDOXHV RI FDURWLG ,07 DUH KLJKO\ GHSHQGHQW RQ the 
methodology used for its measurement. These values are established on the 
basis of the histogram of IMT values for a general healthy population [1.52, 
1.53@ 7KH ³QRUPDO´ ,07 YDOXHV DUH VWURQJO\ LQIOXHQFHG E\ DJH DQG VH[
[1.52]. The upper normal limit for the IMT is frequently set at the 75th upper 
percentile of the IMT distribution. However, since the IMT is considered as a 
candidate marker of cardiovascular risk [1.50], the normal value should be 
interpreted in terms of increased risk rather than in terms of statistical 
distribution within a population. Epidemiological studies should contribute to 
definition of the threshold of the IMT above which the cardiovascular risk 
begins to increase sharply. The epidemiological data currently available 
indicate that an IMT value at or above 1 mm at any age is associated with a 
significantly increased risk of myocardial infarction and/or cerebrovascular 
disease [1.46]. 
A close correlation of the IMT with a number of cardiovascular risk 
factors was demonstrated in [1.54]. Traditional risk factors, such as male sex 
[1.55], ageing [1.55], being overweight [1.55], elevated blood pressure [1.56], 
high blood cholesterol [1.57], diabetes and insulin resistance [1.58] and 
cigarette smoking [1.59] positively correlated with the carotid IMT in 
observational and epidemiological studies in patients from cardiovascular risk 
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groups and from the general population. Among the traditional risk factors, 
hypertension appears to have the greatest effect on IMT, probably via medial 
hypertrophy, which is a process specifically related to this disease [1.57]. 
Cumulative effects of classical risk factors on IMT were shown by a positive 
relationship between the multifactorial Framingham risk score and the carotid 
IMT [1.60]. New or emerging risk factors have also been tested with regard to 
their relationship with the carotid IMT [1.61]. Some of these studies have 
demonstrated a consistent association with the increased IMT, such as various 
lipoproteins [1.61], psychosocial status [1.62], plasma viscosity [1.63] and 
hyperhomocysteinemia [1.64]. Carotid IMT has also been found to be 
associated with cardiovascular alterations or organ damage [1.65]; 
specifically: (i) in the brain with white matter lesions assessed by magnetic 
resonance imaging [1.66]; (ii) in the heart with angiographically assessed 
coronary artery disease [1.67].  
All of the relationships of the IMT to cardiovascular risk factors and 
organ damage indicate that increased IMT may be considered as a 
comprehensive measure of the alterations caused by multiple risk factors over 
time on the arterial walls. The extensive use of the IMT in medical literature 
highlights the major role it currently plays as a biomarker in clinical research 
[1.48]. The Kuopio Ischaemic Heart Disease (KIHD) Study of middle-aged 
healthy Finnish men showed that a carotid IMT of 1 mm was associated with 
a two-fold greater risk for acute myocardial infarction over 3 years [1.68]. 
The Atherosclerosis Risk in Communities (ARIC) study in several US 
communities showed that a carotid IMT of 1 mm was associated with an 
increased risk ratio of coronary event over a period of 4-7 years (a risk ratio 
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of approximately 2 and 5 in 45-64 year old men and women, respectively) 
[1.69]. The CHS Study in elderly US subjects showed that a carotid IMT of 
1.18 mm was associated with a four-fold greater risk for combined acute 
myocardial infarction and stroke over 6 years [1.70]. The Rotterdam Study in 
elderly Dutch subjects showed that each difference of 0.16 mm in IMT was 
accompanied by a risk ratio of 1.4 for acute myocardial or stroke over 3 years 
[1.71]. In addition, studies in secondary prevention, in particular the 
Cholesterol Lowering Atherosclerosis (CLAS) study [1.72] in patients with 
established coronary artery disease, showed that for each 0.03 mm increase 
per year in common carotid IMT, the relative risk for any coronary event was 
3.1. All of these studies demonstrate that increased IMT is a powerful 
predictor of coronary and cerebrovascular complications regardless of the 
method and the site of measurement, including the distal common carotid far 
wall IMT.  
However, the predictive power appears less strong for IMT measured only 
in the distal common carotid than for IMT measured at multiple extracranial 
carotid sites. This supports the idea that the common carotid artery alone may 
not be the most appropriate segment to study if the objective is to predict 
atherosclerotic-related complications [1.48]. 
A number of trials have tested the effects of lipid lowering drugs (statins) 
on the carotid IMT, while other trials have tested the effects of various 
calcium antagonists [1.73]. The outcome of all of the above trials (i.e., the 
IMT measured at multiple carotid sites, frequently including plaque in the 
bifurcation or internal carotid) can be considered as a surrogate of 
atherosclerosis. Therefore, when a drug (such as pravastatin, atorvastatin, 
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amlodipine or ramipril) demonstrates a beneficial effect on the IMT 
progression, the drug can be inferred to exert an antiatherosclerotic effect on 
the carotid walls [1.48] 
These trials on the common carotid IMT highlight three main 
observations. First, the measurement of the IMT in the far wall of a CCA free 
of atherosclerotic plaque allows a perfect image to be obtained of the two 
echogenic lines that define the IMT. Therefore, these two lines can 
automatically be detected using computerized edge detection program. This 
automatic measurement considerably improves the precision and 
reproducibility and therefore allows demonstration of a significant difference 
in the IMT progression between both treatments using a relatively small 
sample size. The CCA is the site of earlier lesions, which are not necessarily 
atherosclerotic in nature when compared to the more advanced lesions in the 
bifurcation or internal carotid arteries [1.48]. 
The IMT-INSIGHT trial has found the same incidence of events 
following nifedipine and diuretic treatment, whereas the IMT progression was 
different between both treatments. The reason is that the common carotid 
IMT reflects a very early preintrusive lesion and its short-term change cannot 
be translated into atherothrombotic complications whose mechanisms involve 
advanced atherosclerotic lesions. Nevertheless, a common carotid IMT 
change is likely to indicate the incidence of clinical complications in the long 
term, but further trials of longer duration are required to validate this 
hypothesis. The carotid diameter change may passively modify wall thickness 
by stretching the artery wall due to the non-compressibility of the arterial wall 
mass [1.48]. 
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Since the carotid IMT is a marker of early arterial wall change, caused by 
atherosclerosis and/or vascular hypertrophy, detection of this change by B-
mode ultrasonography might be of substantial value in diagnosis of high 
cardiovascular risk. This detection may lead to the decision to treat at-risk 
patients with drugs or by correcting modifiable risk factors [1.51].  
Before proposing routine measurement of the IMT in clinical practice, 
several existing limitations must first be resolved. These include 
standardization of measurement methods (including the site and the method 
of analysis of the IMT measurement) and precisely defining the threshold for 
the IMT above which the risk of cardiovascular event can be considered to 
substantially increased for a given individual [1.74].  
The IMT assessed by B-mode ultrasound in superficial large arteries, 
especially the carotid, is of major relevance with regard to the following 
points [1.51]:  
(i) Reflection of multiple risk factors; 
(ii) Mirror of atherosclerotic burden and/or index of cardiovascular 
growth, particularly in hypertension; 
(iii) Predictor of subsequent events;  
(iv) End point for therapeutic trials. 
Identifying the presence of increased IMT in the carotid arteries of one 
individual with intermediate cardiovascular risk would be expected to lead to 
his/her classification in the high risk category and thus to influence the 
aggressiveness with which risk factor modification would be performed 
[1.51]. 
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1.3) Using the ECG signal for medical imaging 
An Electrocardiogram (ECG) is a graphical presentation of the heart 
activity over time. It is recorded by placing electrodes on the human body at 
certain points, and then measuring the potential difference between the 
electrodes caused by the depolarisations and repolarisations of the heart. The 
graphical presentation of the ECG can be interpreted, so that normal and 
abnormal rhythms of the heart can be detected and diagnosed [1.75]. 
Traditionally, these graphical presentations were produced on ECG graph 
paper. Today, ECG machines are compact electronic systems capable of 
automatic interpretation [1.76]. 
The signals picked up from the human body are typically 0.1 ± 5 mV, 
with the bandwidth between .05 and 130Hz [1.77]. Simple heart monitoring 
uses frequencies up to 30Hz, whereas, in some cases (e.g., intensive care 
monitoring), the frequencies of interest increase up to 1 kHz [1.78]. 
7KHJUDSKLFDOSUHVHQWDWLRQVRIWKHKHDUWDFWLYLW\DUHXVXDOO\FDOOHG³OHDGV´
LQPHGLFDO WHUPV7KHZRUG³OHDG´ in electrical terms means the actual wire 
connected to an electrode placed at a particular location of the human body. 
The leads can be both bipolar (the potential difference between two electrodes 
is of interest) and unipolar (the potential of the electrode is related to the 
electrical ground). 
 
 
 
 
Figure 1.12: Frontal Plane ECG electrode placement [1.79] 
P a g e  | 31 
The first type, bipolar limb lead frontal plane ECG, is depicted in fig. 
1.12. It consists of a plane vector with three axes at an angle to each other. 
7KLV SODQH WULDQJOH LV GHULYHG IURP (LQWKRYHQ¶V WULDQJOH, where electrodes 
DUHSODFHGRQWKHSDWLHQW¶VERG\DWWKHSRVLWLRQV$%DQG&IRUPHDVXULQJWKH
corresponding vectors I, II and III, as shown in fig.1.12. Although the 
recordings from any two leads are sufficient for a simple examination, more 
information can be obtained because the third electrode is easily added. These 
leads are the first 3 leads of the conventional 12 lead ECG.  
 
Figure 1.13: Transverse Plane ECG electrode placement [1.79] 
 
Another type of lead measurement is the transverse plane ECG, which is 
also known as the V lead measurement (fig. 1.13). The leads are unipolar 
here. An additional three leads are added at the back of the patient, and an 
extra ground lead would be added if the complete 12 lead ECG were required. 
Four main steps in heart activity are reflected in the ECG signal. 
 
Figure 1.14: P wave generation [1.79] 
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The P wave is generated first. This results from the depolarisation of the 
Sino Atrial node (SA node) (fig 1.14). The SA node is usually known as the 
primary pacemaker and the P wave travels to the Atrioventricular node (AV 
node). The AV node, also known as the secondary pacemaker, is where the 
blood flows from the right and left atrium into the right and left ventricle by 
opening of the tricuspid and bicuspid valves, respectively. The corresponding 
electrical activity is represented as a P wave on the ECG signal, having an 
amplitude of about 0.25mV. This usually takes around 0.11 seconds. Changes 
in the width and shape of the wave indicates a change in depolarisation. 
 
 
Figure 1.15: PR interval generation [1.79] 
 
The following PR interval consists of the AV node acting as a delay (fig. 
1.15), which controls the blood flow from the atrium to the ventricle. It can be 
seen at the PR interval on the ECG signal, where it usually takes from 0.12 to 
0.2 seconds, starting from the beginning of the P wave. If the delay time taken 
is greater than 0.2 seconds, the first degree heart block occurs as a sign of 
coronary artery disease. Some PR intervals show conditions that are more 
advanced, such as the second and complete heart block. A delay smaller than 
0.12 seconds indicates Wolff-Parkinson-White syndrome. 
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Figure 1.16: QRS complex generation [1.79] 
 
The subsequent QRS complex is known as the ventricular depolarisation 
(fig. 1.16). The electrical impulse that travelled to the AV node is propagated 
to the myocardium and muscles of the ventricles by the bundle of HIS and the 
Purkinje conducting system. This results in a contraction of the muscle and 
causes pumping of the blood. The bundle of HIS splits into two branches, 
where the left and the right branches activate the left and right ventricles, 
respectively. Consequently, the ejected blood flows in two directions. The 
blood in the left ventricle flows towards the aorta while the blood in the right 
ventricle flows to the lungs and to the pulmonary artery. The QRS complex is 
similar to the P wave in that they both represent depolarisations. The QRS 
complex looks steeper than the P wave because heart activities in this 
complex are much faster compared to those of the P wave. The QRS complex 
typically takes from 0.06 to 0.10 seconds, starting from the end of the PR 
interval. The peak value of the R wave is around 0.25mV. This value can be 
useful in identifying the correct disease state, such as myocardial infraction, 
cardiac arrhythmia, ventricular hypertrophy and some others. 
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Figure 1.17: T wave generation [1.79] 
 
Finally, the T wave represents the stage where the heart muscles relax 
before initiating the next heart cycle (fig. 1.17). The SA node creates the 
corresponding electrical activity. This stage is usually called the late diastole. 
The T wave duration can vary from patient to patient. The amplitudes of T 
wave are positive in most of the leads; a negative wave indicates coronary 
ischemia.  
The complete ECG signal is shown in fig 1.18. 
 
Figure 1.18: The complete ECG signal [1.80] 
The U wave, which has not yet been discussed, is usually present in most 
ECG traces (50-75%). It can be thought of as arising from inexplicable 
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sources. The inverted U wave seen can be a sign of myocardial ischemia 
[1.81].  
The QT interval is measured from the beginning of the QRS complex 
until the end of the T wave. The QT interval varies from patient to patient and 
from time to time, depending on the heart rate of the patient. It can take from 
0.35 to 0.44 seconds.  
The RT segment connects the QRS complex to the T wave, and normally 
takes from 0.08 to 0.012 seconds. The length of the segment may not be as 
important as is its curvature. If this segment is curved downwards, remains 
flat or takes a shorter time than usual, then it can be an indication of coronary 
ischemia.  
The next segment is the ST segment, from the beginning of the QRS 
complex until the apex of the T wave, also referred to as the absolute 
refractory period (no longer than 0.8 seconds). If this segment takes more 
than 0.8 seconds and if an increase in the isoelectric line (known as the 
baseline of the ECG voltage) is also present, then it could be a sign of 
myocardial infarction.  
The final segment is the PR segment. The PR segment shows how atrial 
polarisation is occurring. 
The ECG can be used for many applications, e.g., it can be used on its 
own for monitoring the cardiac cycle or for diagnostics of heart problems. It 
can also be used, along with other examinations, to allow comparisons of 
different examinations to better diagnose a particular condition. In some 
medical applications, ECG gated machines are used to examine different 
diseases [1.82, 1.83]. However, these triggering systems are not yet common 
P a g e  | 36 
in the field of IMT measurement. In the present project, the ECG signal will 
be used as the trigger for the ultrasonic instrument that measures the IMT. 
The advantage of this type of automated system is that the IMT measurement 
can be obtained at a particular stage in the cardiac cycle. Performing an 
ultrasonic screening program on diabetic patients by experienced radiologists, 
combined with ECG, could help to identify patients at risk of developing 
carotid stenosis and stroke. It could also help to establish recommendations 
for screening and management of carotid atheroma in diabetic patients, 
especially those who show signs of ischemic heart disease in ECG.  
Blood pressure varies during the cardiac cycle (fig 1.19). 
 
Figure 1.19: The in vivo ECG with the different pressures created by the 
arteries [1.84] 
Different blood pressures result in different values for IMT 
measurements. The largest value corresponds to the least blood pressure in 
the arteries. This pressure is caused by a number of different physical and 
physiological factors. Physical factors include, e.g., pushing the transducer 
too deep into the skin, resulting in different IMT measurements. 
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Physiological factors include pressure variations during either systolic or 
diastolic parts of the cardiac cycle (fig. 1.20). 
 
Figure 1.20: M-mode ultrasonic scan of the CCA showing different CCA 
diameter and IMT values depending on the heart activity [1.85] 
After the QRS complex, the heart pumps a bolus of blood up the carotid 
artery via the aorta, as the aortic pressure increases. A delay occurs as this 
bolus propagates from the heart, up the artery and past the point of analysis in 
the neck (shown by the vertical markers in fig.1.20). Once the bolus has 
passed and the carotid artery settles, there is a still period until the next bolus 
passes. When the carotid artery has settled, the IMT measurement can be 
taken. Depending on the heart rate of the patient (slow, normal, fast or even 
irregular), the time that the carotid artery is static will change, so an 
appropriate delay is required.  
 
1.4) Proposed Solution 
Diagnosis, monitoring and curing of various vascular abnormalities could 
be performed using ultrasonic measurements of the blood vessels. These 
measurements are complicated by the low level of reflections from the blood 
IMT 
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vessels (1-2% from the incident energy [1.86]) that results in reduction of the 
signal-to-noise ratio (SNR).  
Reliable measurement of the carotid IMT presents a substantial technical 
challenge because of the VPDOOVL]HRIWKHREMHFWȝPRQDYHUDJHIRUWKH
carotid IMT [1.87]) compared to the wavelength of the ultrasonic waves 
DURXQG  ȝP IRU WKH  0+] RSHUDWLQJ IUHTXHQF\ In addition, the IMT 
varies both short term with the heart activity (up to 25µm per heart cycle 
[1.87]) and long WHUP XS WR  ȝP SHU \HDU >8]). Therefore, in order to 
detect any pathology or any trend, ultrasonic scans must be taken in sync with 
the heart activity, and they need to provide a resolution in the micrometer 
range. Since the changes in thickness to be monitored are very small, this 
requires operation of ultrasonic scanners at high sampling frequencies, much 
higher than 50±100 MHz sampling frequencies that are used by contemporary 
ultrasonic scanners. The measurement resolution of the scans largely depends 
on the sampling frequency of the ultrasonic echoes. If this frequency equals 
100 MHz (a typical value for present day advanced instruments), the echo 
samples are taken every 10 ns (10-8s). During that time, ultrasound propagates 
 QV î  PV    ȝP WKH XOWUDVRXQG YHORFLW\ IRU KXman tissues was 
taken from [1.86], and this figure agrees well with data from the Kaye & 
Laby tables [1.89]). Substantial improvements to the pixel size of 
conventional ultrasonic scan limits could be achieved by using significantly 
higher sampling frequencies. On the other hand, improvements in axial 
resolution for ultrasonic measurements can be achieved by using higher 
operating frequencies of the transducer. The downside of this approach is that 
the ultrasound attenuation notably increases with frequency; therefore echoes 
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from only close range will be available for further analysis. 
These two issues (low SNR of the echo signal and need for high sampling 
frequency) can be addressed by using a novel architecture for ultrasonic 
instruments developed in the Applied Ultrasonics Laboratory of Nottingham 
University. An additional issue is the variability of the blood vessel size, 
which depends on the phase of the cardiac cycle. Several studies have shown 
that these variations with a cycle time of around one second result in the same 
changes as building atherosclerosis over a period of one year.  
The present research will focus on building an instrument that takes 
ultrasonic scans at the required time instant, determined on an ECG diagram, 
and then testing and experimenting with the resulting instrument.  
Primary objectives 
x Develop an ultrasonic medical instrument for carotid IMT 
PHDVXUHPHQWVZLWKDUHVROXWLRQRIȝP 
x Develop medical instrumentation that synchronizers ultrasonic scans 
with the heart activity monitored by the ECG  
x Integrate the above developments in a low cost portable medical 
instrument capable of taking A-mode scans 
Design outcomes 
x Self-contained ultrasonic instrument capable of taking A-mode scans 
in vivo with a sampling frequency above 1 GHz  
x An add-on device that monitors the patient's EGG and triggers an 
ultrasonic scan at a desired phase of the heart activity 
x An integrated instrument that uses a conventional ultrasonic 
transducer for A-mode scans 
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Experimental evidence of success 
x In vivo A-mode scans 
x Consistent A-mode scans taken in vivo at the same phase of the heart 
activity in a space of several minutes 
x A-mode scans synchronized with in vivo heart activity 
The development will enable accurate monitoring of the carotid IMT to 
detect any trends (e.g., related to progression of disease or to an effect of 
some treatment) within a short time of observation. This will enable further 
advances in cardiovascular disease detection and faster development of novel 
medicines. 
 
The new system 
The new proposed system will consist of the following three parts: 
- Front end 
- Processing 
- Back end 
Front End 
 
Figure 1.21: Diagram showing the front end of the system under 
development 
Instrumental 
Amplifier 
& 
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The ECG signal is acquired from the patient (fig 1.21). Safety of the 
patient is of primary importance because, in case of malfunction, a high 
voltage risk can occur to the patient. A battery-operated device can eliminate 
this risk [1.90]. In addition, to eliminate the possibility of high voltage 
appearance via communication wires, a wireless link can be employed.  
 
Processing 
 
Figure 1.22: Diagram showing the receiver end of the system 
 
When the transmitter sends the data acquired from the patient, they will 
be received by the receiver and then used to trigger the ultrasound machine 
for the IMT measurement (fig.1.22). A 9V battery supply for the receiver 
seems to be a better choice than an AC adaptor because it produces less noise. 
This receiver also offers communication over an RS-232 interface, which 
simplifies debugging and allows logging of the received data on a PC.  
 
 
 
 
Receiver PIC 
PC RS-232 
9V Supply 
or 
AC Adaptor 
Trigger 
the acquisition 
of ultrasound 
P a g e  | 42 
Back End 
 
Figure 1.23: Diagram showing the ultrasound end of the whole system 
 
The back end (fig 1.23) includes the ultrasonic instrument that sends and 
receives ultrasonic signals via a transducer. Small changes in IMT will 
require a better time domain resolution, which will be achieved with a 
sampling frequency of around 1GHz.  
 
1.5) Why wireless? 
Today, many electronic devices provide wireless communications. This 
allows people unrestricted mobility as there are no connecting wires. The 
wireless systems that are used in hospitals should not cause interference to 
sensitive instruments located in the close vicinity. Wireless ECG monitors 
can be built using a number of different microcontrollers [1.91]. Of these 
options, the rfPIC from Microchip uses a radio frequency that does not 
require licensing. In addition, an evaluation board for the rfPIC was available 
from the EEE department, making it a logical choice. After the signal from 
the patient is picked by the electrodes, it needs to be amplified by an 
instrumental amplifier. The rfPIC then converts the signal using a built in 10-
bit ADC, and transmits the digital data obtained to the receiver.  
 
Back End 
 
Ultrasound 
Processor 
 
Sampling Trigger 
Front End 
 
Transducer 
 the acquisition 
of ultrasound 
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Chapter 2 - Prototyping the ECG monitor 
 
2.1) Introduction 
There are two different types of ECG recording: the 3-lead ECG and the 
12-lead ECG. The 12-lead ECG (consisting of V1-V6 and also the right leg 
electrodes in addition to the 3±lead ECG) is usually used to obtain detailed 
information about the heart. In the present study, the 3-lead ECG provided all 
the necessary information and thus was chosen over the 12-lead ECG.  
The 3-lead ECG can be taken from the positions near to the heart or from 
each arm. In hospitals, it is preferred to take the ECG near the position of the 
heart because it is more accurate. Additionally, if the patient lies in a bed, the 
electrodes can be fixed more securely. Taking measurements from the arms 
could be inconvenient for both the medical personnel and the patient. These 
two types of electrode placements for ECG recording are shown in fig 2.1: 
   
Figure 2.1: Different possibilities of connecting electrodes [2.1] 
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Both methods are acceptable for triggering ultrasonic scans, and in the 
developed device, the ECG is acquired from the wrists for simplicity.  
The electrodes used in hospitals are designed for a single (disposable) use 
only. However, different types of electrodes such as clamps, chest straps and 
stick electrodes can be employed for testing.  
A questionnaire form (Appendix A on page 178) was sent to doctors in 
different departments, such as cardiology, radiology and cardiovascular, to 
confirm that the decisions made for the development were correct and 
efficient. 
 
2.2) Instrumental amplifiers 
2.2.1) AD624 
This instrumental amplifier was used for a final year project completed by 
Mr. Richard Waddington [2.2]. In his thesis, he analysed the feasibility of 
using a dsPIC for short time measurements of the heart rate. He used an 
AD624 instrumental amplifier for the ECG signal amplification. 
 
 
Figure 2.2: Schematic diagram of an ECG monitor  
that uses AD624AD [2.2] 
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This circuit took the signal from two inputs (positive and negative inputs) 
and output the ECG of the patient. The third input was used as a neutral. The 
resistors in series provided protection to the patient. The diodes placed 
between the AD624 inputs and ground ensured protection of the AD624 from 
electrostatic discharges. The amplification process consisted of a single step. 
The circuit included a low pass filter at the output to eliminate unwanted 
noise. The schematic (fig 2.2) used bipolar leads because of configuration of 
its inputs. 
 
2.2.2) AD620 
 
Figure 2.3: Schematic of the ECG monitor based on the AD620A [2.3] 
 
The AD620 was one of the recommended low power and voltage ICs for 
ECG machines [2.4]. The schematic for the ECG monitor (fig 2.3) uses 
bipolar leads like the AD624 (fig.2.2), but the AD620 uses a two step 
amplification with high pass filtering in between.  
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The other difference is the use of the third electrode, which is connected 
to the leg and acts as a feedback. It is used for a common-mode rejection to 
decrease interference. Finally, this instrumental amplifier offers the choice of 
amplification gain by changing the value of the resistor RG. The required 
value can be calculated using the gain formula provided in the datasheet. 
 
2.2.3) INA326 
 
 
Figure 2.4: Schematic of the INA326 ECG circuit [2.5] 
 
The circuit shown in fig.2.4 is similar to the AD620 instrumental 
amplifier because it also contains the leg driver op-amp and uses a two stage 
amplification with a filter between the stages. The circuit is more complex 
because of its unipolar power supply. Resistors of the same value are added at 
each input in series, which helps to protect the patient from being shocked in 
case of a serious hardware fault. The resistance differs from circuit to circuit 
and it is calculated depending on the circuit. The gain of this instrumental 
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amplifier can be set easily using the information provided in the datasheet 
[2.6].  
 
2.2.4) INA118 
 
This instrumental amplifier already had an example of an ECG monitor in 
its datasheet [2.7]. It was one of the instrumental amplifiers that had a SPICE 
model, which could be used to simulate the operation of the IC under various 
conditions. 
Figure 2.5: Schematic of the ECG monitor based on the INA118 [2.7] 
 
The schematic for the INA118 (fig 2.5) is similar to the previous two 
schematics, as it uses a leg driver and a resistor to set the output gain. It uses 
single step amplification. No output filter is shown in fig.2.5 but one can be 
easily added to the output. 
 
2.2.5) AD623 
Another ECG monitor uses AD623 (fig.2.6, [2.8]).  
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Figure 2.6: ECG monitor that uses the AD623 instrumental amplifier [2.8] 
 
Only part of the complete schematic is presented in fig 2.6 to allow 
comparison of the different instrumental amplifiers in the same conditions. 
Two electrode inputs are shielded and series input resistors are also used to 
protect the patient. This was single step amplification and a low pass filter 
was used at the output to eliminate the unwanted noise. 
 
2.3) Which amplifier to choose? 
 Fig.2.7 presents three ways of implementing an ECG signal amplifier. 
 
 
 
 
 
 
 
 
Figure 2.7: Block diagram of three options for the ECG signal amplifier 
 
Low Pass 
Filter 
 Low Pass 
Filter 
Low Pass 
Filter 
I.A. 
G=8 
I.A. 
G=1000 
 
 
 
I.A. 
G=1000 
Model 2 
Model 3 
Model 1 
O.A. 
G=143 
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The advantages and disadvantages of these architectures are compared in 
fig 2.8. 
Designs Advantages Disadvantages 
Model 1 - Two step amplification has a 
lower noise when compared to 
single step amplification  
- If the value of gain (G) is not 
well decided for both amplifiers 
then this will not give an accurate 
reading  
Model 2 - Less circuitry and one step 
amplification is useful for simple 
ECG machines for experimenting  
- There is no third electrode in the 
system.   
Model 3 - It is better to have some shielding 
for protection rather than having 
none and the noise at the output is 
low  
- The third electrode goes to 
ground but it does not interact 
with the circuit.  
Figure 2.8: Table comparing the amplifiers showing their advantages and 
disadvantages  
 
Each amplifier has its advantages and disadvantages, and all were 
simulated to compare their performance.  
 
2.4) Simulation of the amplifiers 
The amplifiers were simulated using the unrestricted freeware simulation 
program LTSpice form Linear Technology. The noise level and small signal 
AC magnitude responses were of primary interest. 
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Because the instrumental amplifiers are intended for use in an ECG 
application, the Common Mode Rejection Ratio (CMRR) was also 
considered. Higher CMRR can help to cancel out the signals common to both 
inputs. Fig.2.9 shows the results obtained for the amplifiers during their 
simulation in LTSpice. 
 
Amplifier Gain Noise CMRR 
AD620A 213 60uV/sqrt(Hz) 130 dB 
AD624 400 400uV/sqrt(Hz) 120 dB 
AD623 18dB 40uV/sqrt(Hz) 110 dB 
INA118 - 3uV/sqrt(Hz) 125 dB 
INA326 - 800pV/sqrt(Hz) 114 dB 
Figure 2.9: Comparison of the simulation results 
 
Fig 2.9 shows that the AD620A provides the best CMRR, and the 
AD623the worst.  Based on fig.2.9, AD624, AD620A and INA326 were 
selected for prototyping. 
 
2.5) Prototyping the instrumental amplifiers 
Use of a breadboard for prototyping was possible because the ECG 
frequencies did not exceed 150Hz [2.9]. Two breadboards were considered, 
the AD-12 [2.10] and the Matsuhama [2.11] (fig.2.10). The latter was 
selected because its size enabled prototyping all three circuits together, which 
made comparative measurements easier.  
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 Matsuhama KandH AD-12 
Size 243x 195x 20mm 184x 168x 24mm 
Contacts 2420 1906 
Bornes 4 5 
Jump Wire Kit Yes Yes 
Figure 2.10: Comparison of two breadboards 
 
The breadboard was divided in such a way that made it easy to find any 
component and its parent circuit, in case any changes were necessary . Once 
the whole prototyping was completed, each connection was tested with a 
digital multimeter for short circuits and wrong connections before powering 
up the breadboard. The prototyped board is shown in fig 2.11. 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: Prototyped breadboard that includes all of the instrumental 
amplifiers 
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2.6) Testing of the amplifiers on a breadboard 
2.6.1) Potential divider for testing the amplifiers in sinusoidal mode 
As discussed earlier, the human ECG signal can vary between 0.1 and 
5mV. Therefore, the amplifiers needed to be tested using comparable voltage 
levels. A signal generator available in the UDSP Laboratory could produce a 
minimum output voltage of 250mV [2.12]. This voltage was attenuated by a 
potential divider (fig.2.12 presents a one stage divider that created too much 
interference; thus, the two stage divider shown in fig.2.13 was used for 
measurements). 
 
 
 
 
 
 
2.6.2) Supply voltage source 
When a sinusoidal input signal was applied to the assembled breadboard, the 
output noise level was 236.2 mV (fig 2.14). This noise was caused by the 
power supply used (fig.2.15, the noise level is stated at the bottom left of the 
diagram).  
 
 
 
 
Figure 2.14: Output waveform showing high noise level  
Fig 2.13: Final version of potential divider 
 
Fig 2.12: First version of potential divider 
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Figure 2.15: The output voltage of the laboratory power supply (the noise 
level is stated in the bottom left corner)  
 
The power supply datasheet stated that it had a maximum noise level of 
100mVpp [2.13]. This noise level was considered unsuitable for the 
application alone, because the operation of an ECG monitor is subject to 
interference from factors such as: 
- Power-line interference (where harmonics and 50-60 Hz pickup could 
occur from the power mains) 
- Electromagnetic interference, which could occur from other electronic 
devices, with the electrode wires serving as antennas, and noise coupled from 
other electronic devices, usually at high frequencies. 
Therefore, the power supply unit was built on a veroboard and it included 
voltage regulators. Fig.2.16 and 2.17 present the schematic and a photograph 
of the assembled power supply. 
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The assembled power supply provided noise of 7.087mV pp only (fig 
2.18), and ensured much clearer output waveform (fig 2.19).   
 
 
Figure 2.18: AC waveform of the voltage at the output of the developed 
power supply (the noise level is stated in the bottom left corner) 
 
 
 
Figure 2.16: The schematic diagram 
of the developed power supply 
Figure 2.17: Photograph of the 
assembled power supply 
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Figure 2.19: The improved output waveform of the ECG monitor 
 
2.6.3) AD624 testing 
The AD624 was tested first with a sinusoidal input. The gain was set to 
1000 and the output signal is presented in fig 2.20. 
 
 
 
 
 
 
 
 
The magnitude response of the AD624 was measured at the set of 
frequencies (1, 3, 5, 10, 30, 50, 100, 150 Hz), and is presented in fig.2.21. 
After preparation of suitable ECG cables (this is discussed later), an in vivo 
ECG waveform was acquired from a patient (fig.2.22).  
Gain 
Frequency 
(Hz) 
Figure 2.20: Waveform of the output 
signal 
Figure 2.21: Frequency response of the 
AD624 
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Figure 2.22: ECG signal recorded in vivo using the AD624 
 
The P, R and T waves are clearly visible in fig.2.22 whilst Q and S waves 
are obscured with noise. Relevant amplitudes and intervals discussed in 
chapter 1.3 were found within the expected range. The amplitude of the R 
wave (that corresponds to the maximum amplitude of the complete signal) 
was 881.9mV.  
The low pass filter that was used at the output of the instrumental 
amplifier to reject the unwanted noise interference performed well and it was 
decided that this filter (available on the breadboard) would be used for the 
other amplifiers if required.  
 
2.6.4) AD620 
Initially, the assembled circuit did not work, and it was decided to replace 
the leg driver with a resistor, and to use a single resistor to set the amplifier 
gain. According to the AD624, the resistor value was calculated as follows: 
P 
R 
S 
T 
Q 
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14.49 : 
GR
kG  
1
4.49

: 
G
kRG 11000
4.49

: k : 45.49  
Therefore, the circuit was modified as shown in fig 2.23. 
 
Figure 2.23: Modified schematic for the AD620A 
 
 First, the assembly was tested for sinusoidal input signals. The example 
output waveform is presented in fig.2.24, and the magnitude response in 
fig.2.25.  
 
 
 
 
 
 
Figure 2.24: Waveform of the output signal         
 
Instrumental Amplifier Part of output filter of AD624 
Vin- 
Vin+ 
Gain 
Frequency 
(Hz) 
Figure 2.25: Magnitude response of the 
AD620A 
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An example ECG waveform, recorded in vivo from the same subject as 
before, is presented in fig.2.26. 
 
 
 
 
 
 
 
 
Figure 2.26: ECG signal recorded in vivo using the AD620A 
 
Regarding the previous instrumental amplifier, the P, R and T waves 
could be easily identified. However, Q and S waves were obscured with 
noise, as before. The noise level was slightly greater than that obtained with 
the AD624.  
 
2.6.5) INA326 
 
The circuit assembled on a breadboard according to the schematic 
discussed above did not work initially, and it was replaced by a simpler 
circuit from the datasheet, with a low pass filter at the output (fig.2.27). 
P 
R 
S 
T 
Q 
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Figure 2.27: Schematic for single step amplification with INA326 that 
includes the output low pass filter  
 
For the gain of 1000, the datasheet recommends the following values: 
R1 N, R2 0and C2=0.1nF. After this modification, the IC was tested 
for sinusoidal input signals (fig 2.28 and 2.29). 
 
 
 
 
 
 
Figure 2.28: Waveform of the output signal          Figure 2.29: Magnitude 
                                                                                response of the INA326 
 
An example of an ECG, recorded in vivo from the same subject as before, 
is presented in fig.2.30. 
 
 
 
Instrumental Amplifier 
Part of output filter of AD624 
Gain 
Frequency 
(Hz) 
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Figure 2.30: ECG signal recorded in vivo using the INA326 without 
output low pass filter 
 
Regarding the previous instrumental amplifiers, the P, R and T waves 
could be easily identified. Q and S waves were obscured with noise as before. 
The noise level was slightly greater than that for the previously tested ICs. 
Nevertheless, it was decided to use this amplifier as it provided the 
convenience of using a unipolar power supply unlike its alternatives. 
 
2.6.6) ECG pads 
A wide choice of suitable ECG electrodes was available [2.14]. After 
analysis of the questionnaires filled out by medical practitioners (page 178 in 
the appendix A), wet gel flexible disposable electrodes were chosen for use 
[2.15, 2.16]. These electrodes provide the following advantages: 
-  their flexibility allows for better electrical contact as body contours 
are often irregular; 
-  regularly shaped rigid electrodes may not always work; 
P 
R 
S 
T 
Q 
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-  disposable electrodes prevent the possibility of spreading infection; 
-  they have a convenient and secure connector for conventional banana 
plugs. 
Electrode 
Electrolyte 
Skin 
Figure 2.31: The layers between the electrode and the skin [2.17] 
 
The selected electrodes are made out of Ag/AgCl, which has a potential 
difference of +1.2V compared to the Hydrogen electrode [2.17]. Good 
contact between the skin and the electrode is provided by a layer of 
electrolyte (fig.2.31), e.g. saline or an ECG gel. The potential difference 
between the electrodes for the saline and the ECG gel is 0.25mV and 0.47mV 
respectively [2.17]. If the electrodes are not in a good permanent electrical 
contact with the skin, they will pick up extra noise.  
Other reasons for possible poor contact with the skin include motion of 
the patient (even breathing results in slight hand movements) and evaporation 
of the electrolyte after some time. 
 
2.6.7) Connecting the ECG electrodes to the ECG monitor 
The three wires connecting the electrodes to the ECG monitor should be 
of equal length in order to maintain the balance of the ECG monitor input 
stage. The selected ECG pads are connected to the cable with banana plugs, 
and 4mm banana connectors were considered for the input of the ECG 
monitor to maintain consistency of connectors. Use of unshielded wires 
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(fig.2.32) resulted in high level of noise, both for sinusoidal waves and for the 
ECGs. Therefore, shielded wires (fig.2.33) were used instead. 
 
Figure 2.32: Unshielded unbendable wires for connections 
 
Figure 2.33: Shielded bendable wires 
 
Three differently coded cables (green for leg, red for right hand, blue for 
left hand) were prepared and they performed in an acceptable manner. 
 
2.6.8) Filters 
Analogue filtering of the raw ECG signals is required to remove artefacts, 
and a combination of high pass (cut off frequency of 0.5 Hz) and low pass 
(cut off frequency of 40 Hz or above) is recommended for ECG monitoring 
[2.18]. A diagnostic mode would require a high pass filter with a cut off 
frequency of 0.05Hz and different selection of low pass filter with either 40, 
100 or even 150Hz cut off frequencies to allow accurate measurements of the 
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ST segment duration for clinical information [2.18]. Even higher frequencies 
exist in ECG signals [2.19]. Use of a low pass filter with a cut off frequency 
of 40Hz or less results in some loss of important clinical information because 
such filtering decreases the amplitude of the ECG waves [2.20]. However, if 
the cut off frequency is set above 40 Hz, this results in the presence of power 
line interference and muscle artefacts [2.21]. In this development, which 
concerns triggering of an ultrasonic instrument at a specific point in the 
cardiac cycle, the cut off frequency can be lowered. We considered a 20 Hz 
cut off frequency in addition to 40 Hz.  
A filter in signal processing is a circuit that removes specific unwanted 
features of a signal. In this development, different filters could be applied, as 
shown in fig.2.34.  
 
 
Figure 2.34: Diagram showing the interconnection of different filters for 
the ECG monitor 
 
An anti-aliasing analogue filter is required before the analogue-to-digital 
conversion in order to remove spectral components above half of the 
sampling frequency, and the digital filter could reduce the noise further, if 
necessary. Of the types of analogue filters available (namely Bessel, 
Butterworth or Chebyshev), the Bessel filter was selected due to its better 
phase response (flatter group delay) compared to the others (fig. 2.35, [2.22]).  
Instrumental 
Amplifier 
Low pass 
Filter 
Anti-Aliasing 
Filter 
Digital Filter 
(if required) 
Input Output 
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Figure 2.35: Group delays and magnitude responses 
of the considered filters 
 
This feature minimises linear signal distortions to the input signal that 
seemed important for the ECG, as it contains separately triggered pulse 
waves. The digital filtering could be provided by the PIC before the 
transmission.  
$ ³)LOWHU/DE´ program (developed by Microchip [2.23]) was used to 
design the anti-aliasing filter with the cut off frequencies of 20 and 40 Hz. 
The schematics of both of the filters can be found on pages 180-181 in the 
appendix B and C. The frequency response of both the filters created by the 
software is shown in fig 2.36 and fig 2.37. 
 
 
 
 
 
 
Figure 2.36: Calculated frequency response     Figure 2.37: Calculated frequency 
of the 20Hz filter                               response of the 40Hz filter 
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These calculated values were compared with the measured values (fig 
2.38 and 2.39) for the filters prototyped on the breadboard and were found 
compatible. 
         
 
 
 
 
Figure 2.38: Measured magnitude response     Figure 2.39: Measured magnitude 
        of the 20Hz filter      response of the 40Hz filter 
 
The filter with the 20 Hz cut off frequency allowed better rejection of the 
mains interference compared to the other one. Because the mains interference 
was observed as the major noise source during the experiments, the former 
filter was selected for later use. 
 
2.7) Digital filter 
All of the required ECG signals were acquired from the same person in 
order to have a controlled environment for fair comparison. Once all of the 
data were collected from the three instrumental amplifier circuits, they were 
saved in Matlab file format, which could then be used to examine the data 
that were acquired. 
The processing algorithm is shown in fig 2.40. First, the data that has 
been recorded using the digital oscilloscope with a very high sampling 
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frequency (200 kHz) were decimated to the sampling frequency of 1 kHz. A 
linear-phase FIR filter was then created using the Parks-McClellan algorithm 
to digitally filter out the high frequency noise. The raw data of the recorded 
ECG and their frequency spectrum were plotted before and after processing, 
in order to find the correct order and cut off frequency for the clearest ECG.  
 
 
 
 
 
 
 
 
 
 
Figure 2.40: Flow diagram of the digital filtering done in Matlab 
 
The data were collected for all three prototyped amplifiers and the results 
are shown in fig.2.41. It is necessary to mention that the red graph was 
accidentally acquired at the sampling frequency higher than 200 kHz but was 
not detected at the time of the data acquisition. For this reason, the frequency 
of the principal interference appears at a lower frequency than the 50 Hz 
mains frequency, and higher harmonics of the mains frequency are missing 
from the graph.  
Decimation of the original record 
Plotting the raw ECG data and their spectrum 
Reducing the sample frequency 200 times to 1 kHz 
Digital filtering 
Plotting the processed ECG data and their spectrum 
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Figure 2.41: Waveforms and spectra of ECG signals acquired in vivo 
 
Fig.2.41 shows that a substantial level of the mains interference was 
present in the signal, even after the analogue low pass filtering. A band stop 
digital linear phase filter with a notch frequency of 50Hz was designed in 
order to reduce this noise. After considering various values for the filter 
order, the desired magnitude response and the weight function, the filter 
eliminated much of the mains noise, as shown in fig.2.42.    
 
Figure 2.42: Waveform and frequency spectrum of the ECG signals 
processed by the designed digital filter 
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The spectra of the processed signals show that the third and fifth 
harmonics of the mains frequency were intact for two signals. Because of the 
improper sampling frequency, the mains interference was not completely 
eliminated for the third signal. However, the processed signals were 
considered to be sufficient to trigger the ultrasonic scans. 
During subsequent experimentation, the generated trigger signal was 
found to be stable even without using the digital filter, because the triggering 
was related to the well recognisable R wave peak. 
 
2.8) Power supply 
7KHPRVWLPSRUWDQWLVVXHWREHFRQVLGHUHGLVWKHSDWLHQW¶VVDIHW\5XQQLQJ
an ECG machine from the mains power supply adaptor would put the patient 
at a potential risk of an electric shock in the case of fatal equipment failure. 
 
Figure 2.43: Schematic of the voltage doubler and inverter 
 
To overcome this problem, battery powered medical instrumentation can 
be used. A battery (or rechargeable battery, or two or more batteries used in 
series) was estimated to provide at least 3V for the ECG monitor. This 
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voltage would not be sufficient for the operation of the rfPIC, and some of the 
amplifiers discussed above required a bipolar power supply. 
Consequently, the use of a DC/DC converter was considered (fig 2.43). 
Fig.2.44 shows the experimentally measured voltages when the converters 
were prototyped on the breadboard. 
 
 
 
 
Figure 2.44: Table showing the different voltage outputs 
 
The output voltage is lower than two times the input voltage because of 
the voltage drop at the diodes, as described by the following equation: 
 
Vout = 2V ± 2Vf, 
where Vout is the output voltage, Vf is the forward voltage drop of the 
diodes. 
A photograph of the fully completed breadboard is shown in fig.2.45. 
Different parts of the ECG prototype are shown bounded by lines of different 
colours. 
 Voltage In Voltage Out 
Test 1 5 V 9.41 V 
Test 2 3 V 5.15 V 
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Figure 2.45: Photograph of the complete prototype breadboard 
 
2.9) Selection of a microcontroller capable of RF communications 
Several options were available for a design of a microcontroller capable 
of some RF communication [2.24]. After consideration of alternatives, the 
rfPIC was selected because some expertise and development tools for this 
microcontroller were available in the department. The rfPIC can be used as an 
interface between the ECG amplifier and the ultrasound machine to trigger 
ultrasonic scans at a specified time to obtain the IMT of the patient. Another 
advantage of this device is its re-programmability, which allows easy 
debugging. The rfPIC Development Kit was available from the department to 
familiarise with the rfPIC. Of the two operating frequencies available for 
rfPICs (315 MHz and 433.92 MHz that require no license to operate), the 
lower was selected for operation. The analysis of the schematic for the rfPIC 
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development kit [2.25] showed that it can be easily adapted for the ECG 
monitor with some changes to ADC inputs and digital input/output pins, 
shown by dashed rectangles in fig.2.46. 
 
Figure 2.46: Schematic of the rfPIC development kit [2.25] showing the 
modifications for the ECG monitor 
 
Because only minor changes for the schematic were anticipated, it was 
not necessary to prototype the rfPIC part of the ECG monitor on a 
breadboard. 
 
2.10) Voltage reference 
A voltage reference IC produces a fixed voltage independent of factors 
such as the load on the component, power supply voltage and temperature 
changes. Voltage references are used to obtain a specific and exact voltage 
value that is independent of the voltage from the power supply. These voltage 
references are used for variety of precision applications, but mainly for 
analogue-to-digital conversions [2.26]. 
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Figure 2.47: Schematic of the voltage reference 
 
The voltage reference will be used with the rfPIC in order to supply a 
reference voltage of 4.096V for the 10-bit Analogue to Digital Converter 
from the Vref output (fig 2.47). This circuit was prototyped and tested, and 
the results obtained were fully compliant with the datasheet specifications 
[2.27]. 
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Chapter 3 - Development of the PCB for the ECG monitor 
with RF communications 
 
3.1) Introduction 
A printed circuit board is a board with conductive paths that connect 
different electronic components and all of these are fixed on top of a non-
conductive surface. PCBs are widely used today because they are much more 
reliable in operation and cheaper to assemble in quantities compared to 
breadboard or veroboard equivalents. They do require time for their design, 
but once the design is complete, they can be produced in large quantities at 
low cost. 
The EAGLE Layout Editor was used for the PCB design, to document the 
schematic and route the components after placing them on the board. An 
important parameter of a PCB is the number of layers it contains, as 1, 2, 4 
and more layers can be produced. More layers allows for greater flexibility 
but at higher cost of the PCB. For this development, a two layer PCB was 
found sufficient.  
 
3.2) Schematic of the front end of the system 
A PCB can be assembled using traditional holes or the more recently 
developed surface mount devices (SMD). The same component could be 
available in different packages, such as most resistors and capacitors. At the 
time of routing the board, all packages must be defined, and these were either 
taken from the EAGLE libraries or prepared based on the information 
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provided by the EAGLE developers [3.1]. Most of the components used for 
the design were SMDs because this option enabled reduction in the size and 
the weight of the board. 
 
3.2.1) Instrumental amplifier 
At the prototyping stage, the INA326 instrumental amplifier was selected 
for the ECG monitor and the adopted schematic followed the 
recommendations from the datasheet [3.2], with the addition of the low pass 
filter at the output (fig 3.1). 
Figure 3.1: Schematic for the instrumental amplifier prepared in EAGLE 
 
The four additional resistors at the input (two at each input) have their 
values unmarked in the schematic. This was done to allow for some 
experimentation on the assembled board with the cables and electrodes 
attached, as the value of these components can vary across a wide range. The 
values of the resistors R3, R4 and the capacitor C14 ensured the overall gain 
of 1000.  
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The filter used at the output of the AD624 was also used at the output of 
this instrumental amplifier to filter the unwanted noise present in the signal. 
The output after the filter circuit of the instrumental amplifier will be input to 
the active low pass filter. 
 
3.2.2) Input connectors 
A choice was available between case mounted connectors [3.3] and 4mm 
PCB sockets [3.4], and the latter component was selected.  Each wire that 
carries an ECG voltage has two connection ports (fig 3.2) because the wires 
are shielded. A third connector was added to provide a better reference point 
from the leg. R14 was added between the ground of the device and the 
reference (leg) electrode for safety reasons. It would limit the current applied 
to the patient if the ground of the device became subjected to a high level of 
voltage due to some serious failure. These three connectors (fig 3.2) were 
colour coded so that it was easier to distinguish them. 
 
Figure 3.2: ECG wire connectors 
 
Right Arm 
Left Arm 
Right Leg 
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3.2.3) Active Low Pass Filter 
The signal that was acquired from the patient, amplified and filtered, is 
then input to the 4th order low pass Bessel filter with a cut off frequency of 20 
Hz before the ADC conversion. As the recorded voltage at the output of the 
low pass filter had an amplitude of about 800 mV, the active filter needed to 
provide an amplification of about 5 times to better utilise the input range of 
the ADC built into the PIC microcontroller. This voltage should not exceed 
the reference voltage of 4.096V, to prevent the ADC saturation. The FilterLab 
software was used for the design of the active filter (fig 3.3). 
 
Figure 3.3: 4th order 20Hz low pass Bessel filter with the gain of 5 
 
By comparing the schematic of the prototyped 4th order 20Hz low pass 
Bessel filter with a gain of 1 (Appendix B) to the schematic of the 4th order 
20Hz low pass Bessel filter with a gain of 5 (fig 3.3), the first stage of the 
filter was changed in order to provide the required amplification.  
OPA2604AUE4 operating amplifiers [3.5] were selected for the active 
filter, and the complete EAGLE schematic is presented in fig.3.4. 
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Figure 3.4: 20Hz 4th order low pass Bessel Filter with the gain of 5 
 
3.2.4) Power supply 
As discussed in the previous chapter, it was decided that a voltage doubler 
and an inverter would be used to provide necessary voltages from a battery. A 
suitable 3V lithium coin cell battery [3.6] with its holder [3.7] was used as a 
primary power source. The complete schematic including the voltage doubler 
and voltage inverter is presented in fig 3.5. 
 
Figure 3.5: Schematic of the on board power supply 
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This doubler and inverter would supply +5V, -5V, +2.5V, +3V and the 
ground potential for the whole circuit. The schematic fig.3.5 shows the SMD 
diodes [3.8]. A jumper was added to the circuit to disconnect the battery when 
the device was not in use. Another jumper was added to enable powering the 
rfPIC with either 3V or 5V. 
 
3.2.5) Reference voltage 
The voltage reference component [3.9] was created from another library 
component with the same dimensions. The voltage reference was powered 
from the doubled voltage to give an output voltage of 4.096V as a reference 
IRUWKHUI3,&¶V$'& 
 
Figure 3.6: Schematic of the voltage reference (4.096V) 
 
Fig 3.6 shows a jumper that allowed the Cin-/GP1 pin of the rfPIC to be 
used either as a voltage reference input pin (normal operation of the device) 
or as the PGC programming input pin (writing the program into the PIC). 
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3.2.6) rfPIC 
The rfPIC12f675k component description for the PCB design was found 
on the EAGLE website [3.1]. The schematic of the rfPIC development kit 
was adopted, with minor modifications (fig 3.7).  
 
Figure 3.7: Schematic of the rfPIC part of the ECG monitor 
 
An ICSP socket was added to the schematic (fig 3.7) in order to program 
the rfPIC using the PICkit2 debugger/programmer. Five specific pins are 
required for rfPIC programming (namely VPP, VDD, PGC, PGD and GND). 
The PCB design was completed with the PCB loop antenna that had its 
dimensions taken from the rfPIC datasheet. 
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3.2.7) Test points 
Once the schematic was completed, some test points were added before 
and after each stage to allow easy exploration of the signals using an 
oscilloscope. The schematic for the test point is presented in fig 3.8. 
 
Figure 3.8: Schematic design of a test point 
 
3.3) The final schematic 
All the necessary component packages were created and linked to the 
schematic components. The final schematic of the front-end can be seen on 
page 182 in appendix D. The error rule check (ERC) function was performed 
and a copy of the error report produced by EAGLE is shown in appendix E on 
page 183. In total, 11 warnings and 1 error were reported but these warnings 
and error were not found to be important since they were all related to the 
rfPIC package created by another user. A similar issue was experienced with 
the 4mm PCB socket. The socket has 2 pins that could be connected and since 
only one was connected, the software thought that there was an error. 
 
3.4) Printed circuit board of the front end 
The components were manually placed on the PCB and the tracks were 
routed using the autorouter available in EAGLE. The design rule check 
(DRC) was then performed, which checks the design outcome against the 
specifications for a particular PCB manufacturing house (PCB Train [3.10] in 
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our case). Small errors like conductive lines being too close to each other 
were fixed manually after performing the DRC.  
The final design of the PCB and its photographs from two sides are 
presented in fig 3.9 and fig 3.10 respectively. 
 
 
Figure 3.9: Final view of the PCB design of the front end 
 
 
 
 
 
 
 
Figure 3.10: Picture of both layers of the manufactured PCB  
of the front end 
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Chapter 4 - Programming, prototyping 
and testing the ECG monitor on a veroboard 
 
4.1) Changes to the development plan  
 
Because of some personal circumstances, the original registration for the 
PhD degree program was changed to the MPhil degree program soon after the 
point when the PCB was designed and sent for manufacturing. This made it 
difficult to pursue the original work plan, and some changes to it were 
inevitable, in order to complete the design of the instrument in one year. 
Additionally, the RF communication between the ECG device and the 
ultrasonic scan triggering circuit could be undesirable in a hospital 
environment [4.1] and at the same time, it could limit the operating 
frequencies of the ECG device [4.2]. Therefore, the assembly and debugging 
of the PCB was abandoned and another speedier development of the ECG 
part of the instrument took place, which used a veroboard instead. 
 
4.2) The veroboard featuring the rfPIC development module  
 
The veroboard included the ECG connectors, the instrumental amplifier 
and the active low pass filter with a socket for the rfPIC development module 
(fig 4.1). This design allowed for the development of the rfPIC control 
program that would be compatible with the PCB board described in chapter 3.  
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Figure 4.1: Block diagram for the veroboard that included the rfPIC 
development module 
 
4.2.1) ICD header 
The modular connector [4.3] provides the advantage of easy in circuit 
connection of the PIC to the MPLAB IDE development environment, without 
removing the PIC from the socket.  
 
4.2.2) RS-232 
A DB9 RS-232 socket [4.4] was used to interlink the development board 
and the serial port of the computer for debugging. 
 
4.2.3) 5V powered RS-232 transceiver 
Of the options available (e.g., [4.5]), the Maxim-202CPE transceiver [4.6] 
was selected. It generates ±12V signals required by the RS-232 standard from 
a single +5V power supply. The typical operating circuit requires a few 
external capacitors only and is easy to implement [4.6]. 
 
ECG with 
Active LPF 
PIC connector 
for transmitter 
Power sockets 
with regulators 
ECG connectors 
+5V RS-232 
Transceiver RS-232 
Modular connector 
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4.2.4) Board connectors 
 
Four different sockets were used in the circuit. The first one was a 
connector to link the rfPIC development module to the veroboard. The 
module has a 14 pin connector so a 14 pin socket was made out of two (10+5) 
pin sockets [4.7]. The extra pin in the socket was marked to avoid plugging 
the transmitter in the wrong way. The second socket was the BNC socket 
[4.8]. This socket would send the trigger signal from the output of the 
microcontroller to the FPGA board to start the ultrasonic scan. The ECG 
sockets [4.9] (used for the PCB) were also used for this veroboard. Finally, 
two power sockets were used to connect the power supplies, one for the 
positive (+5V) and the other for the negative (-5V) voltage [4.10].  
 
4.2.5) Regulators 
 
The on board circuits require both a +5V and a -5V power supply and the 
power adapters used provided 9V each.  Therefore, regulators were used to 
stabilize the voltages to +5V and -5V. The regulators for the negative [4.11] 
and positive [4.12] power supplies were different to each other and were 
connected according to the relevant datasheets.  
After the selection of the components, the development board was 
designed (Appendix F on page 184) and prototyped (fig 4.2) so it could be 
used to test the ECG monitor in part and as a whole.  
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Figure 4.2: Picture of the completed veroboard 
 
The advantage of having this board (compared to a PCB design) is that 
more than one microcontroller module can be tested. As well, more 
components can be simultaneously added, if necessary. In addition, this type 
of development board could be designed and assembled in the laboratory 
without the delays related to PCB manufacturing. 
 
4.3) Testing of the developed veroboard 
 
First of all, a digital multimeter was used with the schematic of the whole 
board to check for short circuits. Some short circuits were found in the board 
at first. By looking at the top layer, where the components were placed, no 
short circuits could be seen, but after looking in detail at the bottom layer 
with a magnifying glass, very small patches of solder were noted between 
tracks and these caused the short circuits. These short circuiting materials 
were removed with a sharp blade by scratching between the tracks. 
ECG input sockets 
Unregulated -5V 
Unregulated +5V 
BNC socket for 
triggering 
ICD socket for 
programming 
Instrumental 
amplifier 
Low Pass Filter 
+5V Transceiver 
Microcontroller 
socket 
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data logging 
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After that, the whole board became operational, but the output voltage 
was found noisy.  The capacitors at the input of the regulators were changed 
from a 22µF to a 100µF and the output capacitor was changed from 1µF to a 
0.1µF. This change of capacitors vastly lowered the noise level at the output.  
Finally, some jumpers were added at a few points in the circuit to ease 
debugging. One of these jumpers was put at the RS-232 output to 
enable/disable the data logging to the computer. The same thing was done to 
the ECG signal; the jumper was added in between the input of the 
microcontroller and the output of the filter. This made it possible to isolate 
functional parts of the design from each other to inspect relevant output 
waveforms without the influence of loading circuits. 
 
4.4) Programming the microcontroller 
4.4.1) Main Program (wrap.asm) 
The first thing to be done is to link processor specific variable definitions 
to the microcontroller being used. The RF12F675K is used both on the 
development and on PCB boards. Together with the processor-specific header 
files, it starts the program. After this, the configuration bits are set. These bits 
include oscillator selection, code protection, reset, power-up and watchdog 
timer, as well as some pin functions and brown-out detection. Both the data 
and program memory code protections were disabled for the ease of 
debugging. Some peripherals, such as Brown-out detection, power-up and 
watchdog timers, were disabled because they were not required. The 
GP3/MCLR pin, which is connected to a push button, is configured for the 
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master clear (MCLR) function. The internal oscillator 
in the PIC is used for clocking.  
Next, the code defines the variables that are going 
to be used throughout all four programs. The variables 
were typed, line by line, after each other, after a special 
instruction (cblock 0x20) that told the microcontroller 
that the names mentioned here would be mapped to the 
general purpose registers. It is also important to end the 
cblock section by putting an end (endc) to it when 
finished declaring the variables. 
While creating the variables to be used throughout 
the programs, some constants were also defined. These 
definitions enable use of particular constants by name, 
and these can be applied to configuration code, 
constants, pin definitions and register bits.  
Six general-purpose input/output (GPIO) pins were 
available that could be used and they are bi-directional. 
Of these, three were used as inputs and the other three 
were used as outputs. 
The inputs are used for: 
- the analogue ECG signal acquired from the patient 
- reading variable resistor (R1) to set the delay between the peak value 
of the ECG and the ultrasonic trigger 
- an optional input from the RS-232 port.  
 
Include header 
files 
Set the 
configuration bits 
Define variables 
Define constants 
Program 
memory 
organization 
Interrupt 
service routine 
Initialisation of 
the PIC 
Main loop  
Simulation 
instructions 
start 
end 
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The outputs were used for: 
- generation of the rising edge for triggering the ultrasonic instrument; 
- output that used the RF line as wired on the PIC module; 
- an output to the RS-232 cable for communication of the ECG data. 
 
The configurations were defined as constants so it would be easy to 
change them in one place, rather than having to change everything all around 
the program (soft coded configuration). These constants included 
configuration of A/D control register for reading two different channels using 
the ADC module (one channel for the ECG signal, and the other for reading 
the setting of the potentiometer), the configuration of analog select register 
for using different conversion frequencies and configuration of digital 
input/output pins for either output or input as required. A configuration 
constant was also stated for the option register (particularly to set the 
prescaler value). A configuration code had to be created for the comparator 
control register because the comparator is enabled as the default. Therefore, it 
had to be disabled since it was not used in this application.  
Finally, there were two constants, one for marking the output data when 
the trigger occurred and one for a constant value to be used in defining the 
delay to trigger.  
The program memory starts from a reset vector at the address 00h. A 
NOP instruction (no operation) is placed there to allow usage of the ICD (in-
circuit debugger). After this instruction, the program jumps to the initializing 
program that will be discussed later. After initialisation of the hardware and 
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software variables, the interrupts will be enabled. The interrupt service 
routine is located at the address 04h. 
When the main program is interrupted, the control is passed to the 
interrupt service routine (ISR). When this routine finishes, the processor 
returns to the main program again to continue execution of the interrupted 
program by executing the IRET instruction.  
The main section of the program presents an empty superloop, because all 
the required actions are initiated by the Timer0 (T0) interrupt, and are 
performed by the ISR.  
 
4.4.2) Initialisation Program (init.asm) 
This program was written to set the PIC hardware and program variables 
as required before entering the superloop that is interrupted by the timer T0. 
First, the global interrupts were disabled and bank 1 was selected for writing 
the configuration codes. Before setting them in their correct places, the 
factory calibration value for the built-in oscillator was retrieved. After that, 
the general purpose pins were set to input and output, as required. 
The next line sets the option register to the desired prescaler value and 
also links the built in oscillator output to the input of the timer T0. Finally, 
the analogue to digital conversion clock configuration code is set for the 
ADC. Then the code switches back to bank 0, and the comparator is set off. 
After the hardware initialisation, the variables were initialised.  
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Two main variables need initialisation: the first 
one to determine the delay from the peak value of 
the ECG (R wave) to trigger. The voltage at a 
variable resistor will be read to set the required 
delay for triggering the ultrasonic instrument after 
the peak of the R wave. Once the value is read from 
the potentiometer, it would be stored in the variable 
Delay. This value would be sent 10 times over RS-
232 for debugging.  
The second variable that needs initialisation is 
the threshold voltage. The Channel 3 analogue input 
is read by the ADC (this channel is the ECG signal 
that is acquired from the output of the low pass 
filter). After completing the digitising process, it 
will return the value for the ECG sample that will be 
moved into a temporary variable. If this value is 
larger than the previously detected maximum ECG 
voltage, the latter will be updated to this new value. 
This analysis is performed for about 3 seconds to 
make sure that several R peaks are detected. After that, the value is halved 
and is then used as a threshold for the detection of the peak of the R wave. 
The use of this threshold allows cutting off the other waves from 
consideration ± when this level is crossed, the R-wave is detected. It is still 
necessary for every detected R wave to find its peak, which is to be done in 
Disabling 
global interrupts 
Determine delay 
from MAX to trigger 
Sending the 
delay 10 times 
Determining 
the threshold 
Sending the 
threshold 10 times 
Clearing the 
temporary variables 
Setting data 
lines on and off 
Enabling interrupts 
and global interrupts 
Calibrating and 
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the ISR. Finally, the global interrupts and Timer0 (T0) interrupts are enabled 
in the initialisation section. 
 
4.4.3) Subroutines (subr.asm) 
Two subroutines were written: the first one the 
ReadADC subroutine and the second one the SEND 
subroutine. The ADC conversion can be done by calling the 
ReadADC subroutine, and the analogue input channel that 
needs conversion must be selected before this call. When a 
new channel was selected, enough time has to be given for 
circuit switching and this value depends on the charging 
time of the internal capacitor. 
The safe delay was stated as 22µs in the datasheet, and 
a loop that counts down from 7 to 0 wastes 22 instruction 
cycles. This gives a required delay at 4 MHz PIC clock 
frequency because one instruction cycle (Tcy) consists of 4 
clock cycles (Tclk) for the PIC16 microcontrollers. After 
the delay, the A/D conversion starts. 
The DONE flag of the ADC is monitored, and the conversion is finished 
in about 22 µs according to the datasheet and the settings used. Therefore 
getting one sample requires less than 50 µs, and the maximum sampling 
frequency could be up to about 20 kHz. However, this frequency is excessive 
for the ECG monitor, and after the conversion, the ADC module is switched 
off to conserve power. Finally, the subroutine returns control to the calling 
code. 
Send 
ReadADC 
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The second subroutine (SEND subroutine) allows a byte to be sent using 
the RS-232 at a baud rate of 38400. This baud rate was selected because it 
was the maximum rate possible for the wireless RF transmission by the rfPIC. 
Sending one bit of data at this baud rate takes 26µs, and a complete 
transmission of 8 data bits with 1 stop bit, no parity and no flow control will 
take 234µs. Finally, the subroutine will return control back to the position 
from where it was called. 
Therefore, sampling and transmitting a single sample will take less than 
300 µs, and the maximum sampling rate of the ECG signal could be up to 
about 3 kHz. The Timer0 was programmed for the interrupt frequency of 1 
MHz/1024 < 1 kHz; thus, sufficient time was allowed for both the conversion 
and communication to take place in real time for every sample. 
 
4.4.4) Interrupt Service Routine (isr.asm) 
Every time the ISR is invoked, it will acquire an ECG signal sample, 
trigger the ultrasonic instrument if necessary, and send the sample over the 
RF communication. Once it takes control, it clears the T0 interrupt flag so it 
can process the following interrupt request. Channel 3 is used to convert the 
ECG signal that is acquired from the output of the low pass filter. The 
variable Mode will then be used. 
The value mode=0 implies that the ECG signal peak needs to be 
determined, whereas the value mode=1 implies that the maximum does not 
need detection. If Mode=1, then no detection is needed, so the program will 
increment the temporary counter. This value holds the number of samples 
taken after the detection of the peak of the R-wave, and is compared to the 
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desired delay determined in the initialisation code by 
the user (by turning the potentiometer connected to the 
channel 0 of the ADC). If the counter does not reach 
the required value, then the code will send the acquired 
sample. However, if it does reach the required delay 
value, then triggering occurs (this is done by enabling 
the trigger output for the ultrasound acquisition) and 
the marker value (instead of the actual value of the 
sample) will be sent using the SEND subroutine. After 
this, the value of the variable Mode is reset to 0.  
If the value of Mode is 0, a peak of the R-wave is to 
be detected. First, the acquired sample is compared 
with the threshold, and if it is lower than the threshold, 
the sample is sent and processing terminates. 
Otherwise, the monitor processes the R-wave, and it 
will additionally compare the newly acquired sample 
with that previously acquired. If the new sample is 
larger, it will replace the old sample and it will be sent 
wirelessly, terminating the processing. If it is lower, the 
previous sample was the peak of the R wave, the 
sample is sent, the mode is changed to 1 and processing 
is terminated. 
The complete program flow diagram is presented in 
fig.4.3. 
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Figure 4.3: Flow diagram of the overall program showing the interlink between them 
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4.5) Testing the program with the rfPIC microcontroller module 
A program written in Matlab takes the input from the RS-232 PC port, 
connected to the veroboard by a standard cable, and records the output of the 
microcontroller. First of all, the rfPIC microcontroller module (fig 4.4) was 
tested without the ECG input connected (the jumper was removed).  
 
 
Figure 4.4: The rfpic12f675 development module 
 
Therefore, WKHQRLVH LQ WKHFLUFXLWZDV WKH LQSXW WRWKH UI3,&¶V$'&:KHQ
the whole circuit is switched on, the Matlab program will start recording data. 
The rfPIC program could be restarted at will by pressing the RESET button. The 
Matlab program is started by typing the name of the file and, once the script 
starts, the reset button is released. Once the script starts, it will go through a 
number of steps (fig 4.5).  
First, it will clear all of the Matlab workspace variables and it will close the 
open Matlab figures and the serial port. The serial port will then be set to receive 
8 data bits at a baud rate of 38400 through the COM1 port.  
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Figure 4.5: Flow diagram of the RS_Comm script 
The script then checks the validity of the received data. If they are valid, the 
acquisition will continue; otherwise, the program will stop. After some time, 
when enough data are FROOHFWHGWKH³&WUO´DQG³&´EXWWRQVwould be pressed to 
halt the program. When the program is terminated, the data that were recorded by 
then in WKH3&¶Vmemory will be plotted. 
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Figure 4.6: Graph showing the recorded data with no ECG signal 
Fig.4.6 shows a typical record obtained without the ECG signal connected to 
the rfPIC. At the start of the recording, the delay and the threshold values are sent 
after each other (displayed in fig.4.6 by two steps at the beginning of the 
waveform). From the graph, the delay and the threshold values are 172 and 71 
respectively for this record. The delay is used to determine the time between the 
R peak and the instant when the ultrasonic scan is triggered. As PIC 
microcontroller uses 8 bits for data, a delay multiplier was used to extend the 
permissible range of delay values beyond the 8-ELW UDQJH RI « ,Q WKH
program that was used to obtain fig.4.6 this multiplier was set to 2; therefore 
delay setting of 172 resulted in the trigger after 172*2=344 samples after the first 
local maximum was detected. The threshold value to detect the R wave is 
determined by looking for the maximum amplitude of the ECG signal for a set 
time, and halving this maximum amplitude. (This means that during the initial 
observation, the maximum amplitude observed by the ADC was 142=71*2.) The 
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high peaks in fig.4.7 show instances when the trigger signal will be sent to the 
ultrasonic scanner. The whole process was repeated again after connecting the 
ECG signal (fig 4.7). 
 
Figure 4.7: ECG signal received through the serial port that shows peaks for 
the trigger event (the delay for the trigger was set to about 300 samples, the first 
trigger relates to the R peak that occurred outside of the scope of the graph on the 
left) 
Fig.4.7 shows noticeable differences between R-peaks and following triggers 
that could be estimated at approximately ±2.5%. These differences were 
attributed to the remaining noise that resulted in appearances of local maxima in 
the waveform before the actual R-peak. 
 
4.6) Development of a PIC16F688 veroboard module 
Although the rfPIC development module was successfully used for the 
waveform acquisition, it did not allow in-circuit debugging of the program. 
Another PIC module was developed to provide the in-circuit debugging 
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capability useful for program development. This module included a 15 pin 
connector [4.13], push button [4.14], an LED and a PIC16F688 microcontroller 
[4.15] (fig.4.8). This microcontroller was selected because it could be replaced in 
the DIP socket with the pin compatible PIC16F688-ICD part that allows for 
direct connection of the in-circuit programmer/debugger. The photographs of the 
developed module with a conventional PIC and the ICD part are presented in 
fig.4.9 and 4.10, respectively.  
 
Figure 4.8: Schematic of the new veroboard with the PIC16F688 
microcontroller 
 
Figure 4.9: PIC16F688 module with     Figure 4.10: PIC16F688 module  
             with an ICD part                                             with a conventional part   
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4.7) Testing the PIC16F688 module 
This module allowed communication at 115200 baud, three times faster than 
for the rfPIC module. The previously used MATLAB program had to be 
manually halted and a plotting command then had to be entered, again manually. 
The previously used script was modified to accept 5000 samples, plot them and 
then stop (fig 4.11).  
 
Figure 4.11: Flow diagram of the new RS_Comm script 
Counter
<5000 
Setting the serial 
port configurations 
and turning it on 
Valid 
data? 
Closing the serial port and all 
other open Matlab windows 
Scan the serial port and store 
it to the memory 
start 
stop 
Yes 
Yes 
No 
No 
Plot 
Graph 
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At first, the delay was set to a maximum, with no input from the ECG, and 
the reset button was pressed, which was depressed when the script was run. The 
result for the maximum delay is shown in fig 4.12. 
 
 
Figure 4.12: Recorded data with no ECG signal and maximum delay of about 
2000 samples (horizontal axis ± Sample number, vertical ± Amplitude) 
 
At the start of the recording, the delay and the threshold values were sent 
after each other, as before. The delay and the threshold values were 255 and 81 
respectively (fig.4.12). The delay is set by the potentiometer as stated before. In 
order to increase the possible delay time up to 2 s the multiplier for the delay 
setting was increased to 8 for the veroboard module with PIC16F688. Therefore 
the maximum set delay of 255 resulted in the trigger after 8 * 255 = 2040 
samples.  
The delay was left the same and the whole experiment was repeated with the 
ECG (associated jumper closed the circuit) and the recorded ECG is shown in fig 
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4.13. Here, the peak of the R wave is below a code of 100; thus, the threshold 
was below the code 50. Therefore, false triggers were produced by noise, about 
2000 samples after the previous trigger, as the noise exceeded the threshold for 
the most of the waveform. Because of the increased level of noise, compared to 
the rfPIC module, the rfPIC was used for triggering the ultrasonic instrument. 
The debugging option was not used, as the previously described program covered 
all of the needs of the ECG monitor. 
 
Figure 4.13: The recorded ECG signal with the false trigger events 
(horizontal axis ± Sample number, vertical ± Amplitude) 
 
This output trigger signal from the rfPIC module was delayed after the peak of 
the R wave by the time set by the potentiometer (fig.4.7). The results presented in 
this section demonstrated that the developed ECG monitor produced both digital 
output for the ECG signal samples and trigger signal as required. However there 
was a slight disparity in the detection of the R-wave, likely due to remaining 
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noise. The development of the instrument progressed to the FPGA modification 
stage. 
 
4.8) References: 
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Upson, First Published June 2008, IEEE Spectrum, 
http://www.spectrum.ieee.org/jun08/6405 
[4.2] Embedded wireless transceivers and applications in lightweight wearable 
platforms, Mathew Laibowitz and Joseph A. Paradiso, Responsive 
Environments Group, MIT Media Laboratory, 
http://www.media.mit.edu/resenv/pubs/papers/2003-12-
circuit_cellar5.1.pdf 
[4.3] MPLAB ICD 2 In-&LUFXLW'HEXJJHU8VHU¶V*XLGH
http://ww1.microchip.com/downloads/en/DeviceDoc/51331c.pdf 
[4.4] Datasheet of 8LCM009S-304B-XX ² MULTICOMP, 
http://www.farnell.com/datasheets/32792.pdf 
[4.5] Choosing the Right RS-232 Transceiver, http://pdfserv.maxim-
ic.com/en/an/AN2020.pdf 
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MAX214.pdf 
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Chapter 5 ± Operation of the ultrasonic instrument  
and its modification for external triggering 
 
5.1) Operating the ultrasonic instrument  
The ultrasonic scanner developed in the applied ultrasonic device is triggered 
manually and it required modifications in order to be used with the trigger from 
the ECG monitor. The graphic user interface (GUI) for the existing system is 
shown below (fig.5.1), and was used without changes. The operation of the 
ultrasonic instrument is initiated by pressing the ³0HDVXUH´*8,EXWWRQILJ. 
After that, the instrument produces the excitation signal and receives the echo, 
according to the parameters selected by the user (fig.5.1). 
 
Figure 5.1: Screenshot of the GUI for the existing ultrasound system 
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Two sets of parameters are used for excitation of an ultrasonic pulse and 
acquisition of the echo. Excitation refers to the generation of the ultrasonic pulse, 
using the output FPGA signal that triggers the external ultrasonic pulser receiver 
(UPR). For the developed application, it was desirable to set the pulse repetition 
frequency (how many excitation pulses are produced within 1 second) as high as 
possible. The higher the pulse repetition frequency, the smaller the measurement 
time; thus, an accurate scan can be obtained. The reason for this is that the artery 
and blood can be considered static for a short time only. On the other hand, 
setting this frequency too high can result in artefacts if there are echoes with 
substantial amplitudes from the previous excitation that arrive after the following 
excitation. These echoes will be superimposed with the proper echo signal 
related to the following excitation, and it will be not possible to eliminate them. 
The higher the pulse repetition frequency, the lower the depth will be that the 
signal can travel and vice versa. This can be shown using the following formula: 
f
T
T
f 11   , 
where f is the pulse repetition frequency, T is the interval between excitation 
pulses. All the echoes with substantial amplitudes must have delay less than T.  
The total measurement time can be seen in the acquisition parameters panel, 
where it is calculated automatically based on the requested interleaving factor 
and number of averages. For our application, ³([FLWDWLRQW\SH´LV³VLQJOHSXOVH´
(there are some other types available, namely chirp pulse, Golay code, Barker 
code and M sequence). The pulse length value shown in the GUI panel 
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³([FLWDWLRQ SDUDPHWHUV´ LV XVHG WR WULJJHU WKH 835 while the duration of the 
excitation pulse is controlled separately using WinUPR software. This is set to a 
half-SHULRG RI WKH WUDQVGXFHU¶V FHQWUDO IUHTXHQF\, to maximise the amount of 
electrical energy converted into ultrasonic wave energy. In turn, the excitation 
pulse length determines the axial resolution (the minimal distance between two 
separate objects that produce non-overlapped echoes), as follows: 
Axial Resolution = Pulse Length × Wave Velocity 
 
Therefore using as high frequency transducer as possible is advantageous for 
increasing the resolution. We used a 20 MHz transducer instead of the 5-8 MHz 
transducers commonly used in ultrasonic scanners. 
The echo that is acquired is the signal received back from the body of the 
subject, after the propagation of the excitation pulse. The acquisition parameters 
are set depending on the desired accuracy of the acquired signal. These 
parameters include the sampling scheme, ADC sampling frequency, its effective 
sampling frequency, the number of averages and the automatically calculated 
time for one measurement. 
Increases in the ADC sampling frequency and/or in the number of averages 
increase the accuracy of the acquired signal at the expense of the measurement 
time. The time from one peak of the R wave to the following peak can be 
calculated as: 
Maximum pulse rate = 180 beats/min => 3 Hz 
f = 1/T => T= 1/f = 1/3 = 0.3 seconds 
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Therefore, the acquisition time must be well below 0.3 seconds in order to 
statically interrogate the CCA. The sampling scheme consists of two numbers, 
where the first number is the multiplier of the base clock frequency for the 
excitation part, while the second number is that for the acquisition part. These 
numbers define the interleaving factor ± or how many times the excitation must 
be repeated in order to complete a single signal record. For example, the 26-27 
sampling scheme means that the effective sampling speed is 27 times faster than 
the operating frequency of the ADC. This relationship allows maintenance of a 
precise time shift from one excitation to another, and reconstruction of the 
complete waveform by interleaving the samples, obtained from all of the 27 
subsequent acquisitions. The interleaving factor (27 as discussed above) is 
multiplied by the ADC sampling frequency (20-100MHz, defined by the ADC 
installed on the Xtreme DSP board) to get the equivalent sampling frequency. 
 
The equivalent sampling frequency is shown directly in fig.5.1. Finally, the 
number of averages has a range of 2 to 32768, in steps of two. By looking at the 
calculated result for the total time for one measurement, one can find a 
compromise between the sampling scheme, ADC sampling frequency and the 
number of averages needed to achieve the required measurement time. This is 
shown in fig 5.2 using examples for the pulse repetition frequency of 10 kHz. 
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Sampling 
scheme 
ADC 
Sampling 
frequency(MHz) 
Equivalent 
sampling(MHz) 
Number 
of averages 
Total 
time for 
measurement
(s) 
26-27 100 2700 2 0.0054 
4-5 100 500 128 0.0639 
Figure 5.2: Measurement time versus different combinations of parameters  
 
The number of averages (rather than the sampling scheme) determines the 
reduction in the amplitude of the additive noise. This noise can obscure echoes of 
interest if the amplitude of the latter is comparable with the amplitude of noise. 
However, any increase in the number of averages results in a proportional 
increase in the measurement time. In order to balance the noise reduction with 
the measurement time, the sampling scheme of 4-5 with the ADC sampling 
frequency of 100 MHz and 128 averages will be preferred but other setting will 
also be tried. 
The number of excitations to complete a single interleaved and averaged 
record can be calculated using the following equation: 
Number of Excitations = Number of Averages x Interleaving factor 
 
From the number of excitations, the total acquisition time can be calculated by 
using the pulse repetition rate: 
Total Acquisition Time = Number of Excitations / Pulse Repetition Rate 
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Finally the Total Acquisition Time can be related to the time from one peak of 
the R-wave to the following peak: 
Ratio = Total Acquisition Time / R-R time interval 
 
If this ratio is a low number, fewer changes in the blood flow occur during the 
measurements, and the ultrasonic scan becomes more accurate. For a blood pulse 
rate of 180 beats/min, ultrasonic pulse repetition frequency of 10 kHz, 
interleaving factor of 5 and 128 averages, the Ratio becomes: 
Ratio = ( 5 * 128 / 10,000Hz ) / 3s-1  § 
 
Consequently, in these conditions, it is possible to take 50 non-overlapped 
measurements for a single cardiac cycle as sufficient. After setting the 
acquisition parameters, the first and the second acquisition windows are set. The 
purpose of the two acquisition windows is to see the whole A-mode scan in two 
parts, rather than one whole scan, because the amount of memory available is 
limited and may not hold the complete echo record. For the first acquisition 
window, the delay and its duration will be set to see the excitation pulse itself; 
whereas, for the second acquisition window, the delay and duration will be set to 
record the echoes from the CCA boundaries. The delay for the second window is 
the time that is required after the excitation pulse for the ultrasonic wave to 
propagate to the CCA and back, while the duration is the time for the wave to 
propagate from inside the CCA and back.  
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The delay and duration variables for the second acquisition window can be 
found by calculations based on fig.5.3.  
 
Figure 5.3: Diagram showing the approximate depths in the subject 
 
The expected approximate CCA diameter is around 6.5mm, and the CCA is 
expected to be located at a depth of 4.3 mm. The above mentioned acquisition 
parameters for the second window then equate to: 
Delay = s
sm
mml P7.5
/1500
23.4
c
2  u u ; 
Duration = s
sm
mml P7.8
/1500
25.6
c
2 
  u u  
At the time of measurement, the expected delay was lowered in order not to miss 
the beginning of the echo, while the expected duration was increased in order not 
to miss the end of the echo from the CCA. The GUI checks the entered values for 
validity and automatically transforms these to the binary values used by the 
Xtreme DSP board. 
The results can be accumulated to either the HDD (hard disk drive) or the 
RAM (Random Access Memory). The HDD option will be selected in the 
³DFFXPXODWHUHVXOWV´SDQHO; thus, the data can be easily archived for later use. 
 
CCA 
Ø6.5mm 
4.3mm 
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A waveform viewer can be invoked to inspect archived data from previous 
scans from the main coQWUROSDQHOILJ7KH³ORDGFRQILJ´EXWWRQFDQEHXVHG
to load the configuration settings from a specific previously saved scan. After 
FKHFNLQJWKDWDOOWKHSDUDPHWHUVDUHVHWFRUUHFWO\WKH³PHDVXUH´EXWWRQILJ
can be pressed to start the ultrasonic scan The message box (fig.5.4) then 
prompts the user either to continue measurements or to exit (this option allows 
addition of more records to the present set of scans).  
 
Figure 5.4: Message prompting the user either to acquire one more record or 
to archive the present set of records 
 
:KHQWKHXVHUDFTXLUHVWKHGHVLUHGVFDQVWKH³6WRS´EXWWRQLVSUHVVHGWRUHWXUQ
to the main windows (fig 5.1). 
 
5.2) Changes to the design of the ultrasonic instrument  
The ultrasonic instrument itself, developed in the applied ultrasonics 
laboratory, is a complex device that was designed using combination of various 
CAD tools (System generator, Xilinx ISE etc)  and consists of various electronic 
integrated circuits (FPGA, ADC and DAC all assembled on the Xilinx Xtreme 
DSP development board). Therefore, some preliminary familiarisation was found 
P a g e  | 130 
essential, and references [5.1-5.4] were used extensively throughout the 
development. 
7KHZKROHSURMHFWZDVDQDO\VHGLQRUGHUWRILQGWKHSURFHGXUHIRUWKH³5XQ´
button, because the external trigger would interact with it. Looking at the 
diagram for this procedure (fig 5.5), WKH³5XQ´button can be seen to be defined 
DVDSRUW:KHQHYHUWKH³5XQ´EXWWRQLVSUHVVHGWKHFOLFNZLOOEHUHDG by the 
input port (in_start), transferred into the register (Register2) and casted into the 
required format (Convert5) to initiate the waveform acquisition. 
 
Figure 5.5: Diagram of the Start procedure 
 
The FPGA board has 2 DACs, 2 ADCs and 1 CLK port. The DAC1 and 
ADC1 are used for the excitation and acquisition, respectively. The ADC2 port is 
unused; thus, it can be used to input the external trigger signal to the FPGA 
board. A flow diagram (fig 5.6) shows the operation of the system with external 
triggering. 
 
 
 
Figure 5.6: Flow diagram of the modified version of the Start procedure 
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Comparator 
ADC>Threshold 
 
OR 
Start 
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The above flow diagram was implemented using System Generator as shown 
in fig 5.7, but this did not work.  
 
Figure 5.7: Implementation of the modified version of the Start procedure 
 
An additional design that had output displays was used to check the 
correctness of operation of the ADC2 (fig.5.8), and the ADC2 operated 
satisfactorily. 
 
Figure 5.8: System Generator diagram for testing the ADC2 
 
The next modification included addition of new ports to the VHDL code, and 
connecting the necessary port to the principal design, shown as a black box in 
fig.5.10. The updated design is shown in fig 5.9. 
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Figure 5.9: System Generator diagram with additional ports 
 
However, this design also failed to work. Further analysis showed that simply 
bypassing the manual triggering was not possible. Therefore the next design used 
some parts of the design responsible for manual triggering (fig.5.11).  
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)LJXUH'LDJUDPRIWKHFRQQHFWLRQVRIWKHLQVWUXPHQW¶VGHVLJQWKH
Black box in the centre) to the input and output ports 
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Figure 5.11: Block diagram of triggering that includes the procedure  
for the start button 
 
As the trigger signal is activated from the ECG front end and is digitized 
using the ADC2, it will be compared with the threshold by the comparator. When 
the threshold is exceeded, the trigger will start the ultrasonic instrument. 
Whenever the start button is pressed from the acquisition window, it will set the 
RS trigger to the high level (1), which will allow triggering to occur. If the 
acquisition is completed, then the RS trigger will be reset to the low level (0), 
blocking triggering completely. The AND gate will trigger the ultrasound 
machine when the RS trigger is set (i.e., the start button was pressed in the GUI) 
and the trigger signal arrives. This block diagram was implemented in System 
Generator, as shown in fig 5.12. 
onboard 
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& 
R 
 
S 
Acquisition 
completed 
Start 
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Figure 5.12: Final System generator diagram  
 
This design was first simulated using the diagram in fig.5.13, and it worked 
as expected.  
 
Figure 5.13: Design showing the required displays 
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5.3) Testing the ultrasonic instrument with the external trigger mode 
 
A trigger source (fig 5.14) was built on a veroboard to test the design. It 
produced voltage, acceptable for the FPGA board (from -1V to +1V), and 
matched its 50 Ohm input impedance (fig.5.14-5.15).  
 
 
 
 
 
 
Figure 5.14: Schematic of the trigger source    Figure 5.15: Prototyped trigger source 
 
Various pulses can be generated by pressing the push button on the veroboard 
(fig 5.16), and their amplitude can be changed by adjusting the potentiometer. 
 
Figure 5.16: Example output waveform of the trigger source  
 
The trigger source described above was sufficient for testing the design, 
because the RisingEdge component of System Generator reduces incoming 
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pulses of arbitrary duration to short pulses. (The ECG monitor itself outputs a 
short trigger pulse at the required part of the ECG signal.)  
When the trigger source was connected to the FPGA board, the modified 
system was tested and showed that it operated as required. It waited until the 
³VWDUW´EXWWRQZDVSUHVVHGE\WKHXVHUDQGVWDUWHGWKHDFTXLVLWLRQZKHQWKHSXOVH
arrived from the trigger source.  
Finally, the trigger output of the ECG monitor was connected to the ADC2, 
and the operation of the ultrasonic instrument was tested with an ECG signal 
WDNHQ LQ YLYR $IWHU WKH ³VWDUW´ EXWWRQ ZDV SUHVVHG E\ WKH XVHU WKH IROORZLQJ
trigger signal from the ECG monitor triggered the ultrasonic instrument. When 
the acquisition was finished, the user could produce more records at the same 
point of the cardiac cycle if necessary. 
 
5.4) References: 
[5.1] H63HDL lecture notes 
[5.2] 
http://www.xilinx.com/support/documentation/sw_manuals/sysgen_gs.pdf 
[5.3] 
http://www.xilinx.com/support/documentation/sw_manuals/sysgen_user.pdf 
[5.4] 
http://www.xilinx.com/support/documentation/sw_manuals/sysgen_ref.pdf 
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Chapter 6 ± In vivo experiments 
 
6.1) Locating the Common Carotid Artery (CCA) 
Having read different articles and books on how to examine the CCA using 
ultrasonic transducers, the most appropriate way appeared to be to take 
longitudinal images from 3 imaging planes (fig 6.1). This helps in better analysis 
of the IMT, since it gives a rough 3D analysis. In addition, the left and the right 
CCA are measured to check for any inconsistencies between the left and right 
CCAs. 
 
Figure 6.1: Planes of viewing the Common Carotid Artery (CCA) [6.1] 
 
Additional aids, such as the Meijer arc (fig 6.2), can be used to help 
standardise transducer angles for different patients. All of the transducers 
referenced in the literature are B-mode transducers, which scan wide areas rather 
than the one point as the A-mode transducer does. 
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Figure 6.2: Using the Meijer arc to standardize the transducer angle [6.2] 
 
This project intends to use a single A-mode transducer to prove that it is 
feasible to assess the IMT of the CCA at the same point in the cardiac cycle. 
Instead of using the Meijer arc, the CCA was located by going 1.5 inches above 
the joint between the breastbone and the collarbone [6.3]. 
 
6.2) Setting the analogue front end  
As was discussed above, the GUI of the existing ultrasonic instrument was 
used. It is also necessary to control the analogue front end (ultrasonic pulser 
receiver ± UPR- developed by NDT Solutions) to set the width of the excitation 
pulse and the gain for the received echo, using a separate application WinUPR 
(fig.6.3).  
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Figure 6.3: The GUI of WinUPR 
 
The signal parameters are shown on the left of the GUI window (fig 6.3). 
These parameters depend on the transducers used as well as on the object under 
test. If a 20MHz transducer is used, then the pulser centre frequency would be set 
to 20MHz ± 0.1 MHz.  
The pulse repetition rate has the same meaning discussed above, if the 
internal trigger is used. However, in our experiments the UPR was triggered 
externally and this value can be set arbitrarily. The pulser output voltage can vary 
from 10V to 100V (lower voltage is used for lower noise environments).  
The last parameter on the left side is the amplifier gain. This can be increased 
up to 56dB and is set to the value that does not saturate the ADC (-«9LQSXW
range).  
On the right side of the GUI window are found buttons that define how the 
UPR operates and how it accepts the control parameters. The pulser-receiver 
system is connected to a computer via the parallel port and its port address is 
defined by the appropriate button.  
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As only one A-mode transducer will be used, the pulser input and output are 
connected to the same TRX1 socket. Finally, the trigger source will be external 
(produced by the ultrasonic instrument), whereas the pulser source will be 
internal (the pulse is generated by the UPR). The WinUPR GUI offers an option 
to save or load the settings from a previous scan, which was helpful when 
different transducers were used. 
 
6.3) Taking ultrasonic scans 
A 20 MHz transducer with a plastic buffer (or, informally, Dµshoe¶) was used 
for the scans. The buffer has two purposes in ultrasonic NDT. First, it provides a 
layer with an intermediate value of acoustic impedance between the high 
impedance of the transducer with the metal face and low impedance of the 
human tissue that is close to the acoustic impedance of water. Second, it 
eliminates the dead zone ± the part of the object of interest closest to the 
transducer. This part cannot be seen without a buffer because, immediately after 
the excitation, the transducer discharges for some time and this process obscures 
the echo.  
When the transducer with the buffer was operating in air, the delay and 
duration for the first acquisition window were determined from the received 
waveform. This was set to show the reflection from the buffer ± air interface; that 
is, the moment when the ultrasonic wave enters thHSDWLHQW¶VERG\7KHH[SHFWHG
delay for the second window (see chapter 5.1) was extended by this time. 
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Fig.6.4 presents a complete set of parameters set for the ultrasonic instrument 
used in experiments.  
Sampling 
scheme 
ADC 
sampling 
frequency 
(MHz) 
Number of 
averages 
First 
window 
delay (µs) 
First window 
duration (µs) 
Second 
window 
delay (µs) 
Second 
window 
duration(µs) 
4-5 100 128 5.88 2.24 10.92 14.4 
Figure 6.4: Settings for the ultrasonic instrument using 20 MHz transducer 
 
At first, the interleaving factor was kept low (value of 5), while the number 
of averages was set to 128 (fig.6.4). The total time taken for one measurement 
was 0.064 seconds. It was decided to take three records, with each subsequent 
record starting at the end of the previous one, per one trigger, to see changes 
among these records.  
The settings for the UPR are shown in fig.6.5. The amplifier gain was set 
to the maximum value because the echo signal was very weak. 
Pulser Centre 
Frequency(MHz) 
Pulser Repetition 
Rate (kHz) 
Pulser Output 
Voltage (V) 
Output Gain 
(dB) 
20.1 1.0 30 56 
Figure 6.5: Settings for the UPR using 20 MHz transducer 
The measurements were archived for detailed off line analysis, and were 
viewed on a computer using Matlab scripts (e.g., fig.6.6). 
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Figure 6.6: Three superimposed A-mode scans of the CCA with a 20MHz 
transducer with a buffer (horizontal axis ± WLPHLQȝVYHUWLFDO axis ± recorded 
voltage in V) 
 
Additional Matlab script was used to find the time when the waveform 
crossed the zero level, close to two points on the zoomed in graph specified by 
the user, and to calculate the time difference between the two. For example, for 
the markers shown in fig.6.6, the following delays were calculated:  
- between marker 1 and 2 -  ȝVPP 
- between markers 2 and 3 - ȝVPP 
These markers were put at the expected positions for the front wall intima-media 
(between markers 1 and 2) and the lumen (between markers 2 and 3). The 
distances in brackets were estimated assuming that the velocity in human tissues 
is close to that in water (1480 m/s), and accounting for the forward propagation 
of the excitation wave and back propagation of the echo: 
 
2
VelocityDelayDistance u 
 
Marker 1 Marker 2 Marker 3 
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The waveforms for three consecutive scans are presented in fig.6.7, 6.8 and 
6.9.  
Fig 6.7: The first scan of the three measurements for fig 6.6 (horizontal axis ± 
WLPHLQȝVYHUWLFDO± recorded voltage in V) 
 Fig 6.8: The second scan of the three measurements for fig 6.6 (horizontal axis ± 
WLPHLQȝVYHUWLFDO± recorded voltage in V) 
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 Fig 6.9: The third scan of the three measurements for fig 6.6 (horizontal axis ± 
WLPHLQȝVYHUWLFDO± recorded voltage in V) 
These three waveforms were found compatible and consistent, although 
subtle differences were observed. The differences were attributed to noise 
influence and differences in blood flow at different times. Waveforms (fig 6.6 
and fig.6.7-6.9) show that the echoes were weak and that the buffer returned a 
VWURQJ EDFN HFKR DW DERXW ȝV 7KLV HFKR ZDV UHODWHG WR UHYHUEHUDWLRQ RI WKH
ultrasonic wave inside the buffer, and it was not related to the echo coming from 
the patient. The presence of the strong echo from a buffer obscured echo 
returning from the patient at these time instants. However using the buffer was 
essential in order not to obscure the echo from the patient with the excitation 
pulse. Using a buffer for this purpose is a common practice for ultrasonic NDE 
measurements. According to fig.6.10 [6.4], taken in B-mode, the following layers 
should be identified from an A-mode scan: adventitia layer, the front wall, the 
lumen where the blood travels, the back wall and then the adventitia again.   
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Figure 6.10: B-mode scan of the CCA [6.4] 
 
The thicknesses for these layers, taken from different sources, are presented 
in fig.6.11. All were found compatible with the A-scan waveform given above, 
assuming the ultrasound velocity in human body to be roughly equal to the 
ultrasound velocity in water (around 1480 m/s). 
Thickness (mm)  [6.5]  [6.6]  [6.4] 
Adventitia (d) 1-3 1-4 1-5 
Front wall IMT (a) 0.65 0.49-0.83 0.518-0.717 
CCA Lumen (c) 7.72 6.82-8.7 5.310-7.460 
Far wall IMT (b) 0.65 0.49-0.83 0.518-0.717 
Figure 6.11: Different CCA-related thicknesses reported in literature 
 
In addition to the 20MHz transducer, the 4.3MHz transducer was also 
employed to assess the advantages provided by using a higher frequency. The 
parameters for the GUI were amended, as shown in fig 6.12. The delay for the 
first acquisition window was derived from the received waveform, as was 
described above for the 20 MHz transducer. 
c 
Adventitia (d) 
Lumen- Intimal Border 
Media-Advential Border 
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Sampling 
scheme 
ADC 
sampling 
frequency 
Number of 
averages 
First 
window 
delay(µs) 
First 
window 
duration(µs) 
Second 
window 
delay(µs) 
Second 
window 
duration(µs) 
 
4-5 100 128 5.88 2.24 10.92 14.4 
 
Figure 6.12: Settings for the ultrasonic instrument using 4.3 MHz transducer 
 
The required WinUPR are presented in fig 6.13. 
Pulser Centre 
Frequency(MHz) 
Pulser Repetition 
Rate (kHz) 
Pulser Output 
Voltage (V) 
Output Gain 
(dB) 
 
4.3 1.0 30 56 
 
Figure 6.13: Settings for the UPR using 4.3 MHz transducer 
 
The waveform that was acquired with the 4.3MHz transducer is presented in 
fig.6.14. 
 
Figure 6.14. Three superimposed A-mode scans of the CCA with a 4.3MHz 
transducer with a buffer (horizontal axis ± WLPHLQȝVYHUWLFDO± recorded voltage 
in V) 
Markers were put at the expected positions for the intima media. The front 
wall thickness can be calculated from the delay between the Mff and Mfb markers, 
Mff Mfb Mbf Mbb 
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whereas the Mbf and Mbb markers determine thickness of the back wall. The 
delay between Mbf and Mfb determines the diameter of the lumen. The delays in 
the front wall, in the lumen and in the back wall were found to be 2.2 µs, 9.68 µs 
and 1.64µs, respectively. In the pulse-echo mode, the 
c
l 2u W   formula can be 
used to find the thicknesses of different layers. These thicknesses were estimated 
at 1.65mm, 7.26mm and 1.23mm for the front wall IMT, the lumen and the back 
wall IMT, respectively.  
The waveforms for the 4.3MHz transducer were less clear compared to those 
obtained with the 20MHz transducer. The reason for this is the different duration 
of the excitation wave, which takes several cycles of the central frequency of the 
transducer. The number of these cycles increases with the decrease in the 
transducer bandwidth. For the same relative bandwidth, the 20 MHz transducer 
would produce about a 5 times (20/4.3) shorter pulse, and the reflections from 
close objects would be less likely to superimpose. The distance between two 
close objects that can be distinguished on an A-scan is referred to as axial 
resolution (e.g., [www.medcyclopaedia.com/library/topics/volume_i/a/axial_ 
resolution.aspx]) 
Many reasons could exist for differences between the waveforms obtained 
using the above mentioned (4.3MHz and 20MHz) transducers, but one of the 
main sources for these differences was the diameter of the transducer. The 
diameter of the 20MHz transducer was 3mm, but was 5mm for the 4.3MHz 
transducer. The larger diameter of the transducer does not mean that it is better; 
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in fact, it is worse for the IMT measurements, as the transducer illuminates and 
received echoes from the tissues outside the region of interest (fig.6.15). A 
conventional B-mode ultrasonic transducer has 128 elements per 5cm. This 
means that the element size is around 0.4mm, or much smaller than the 
transducers used in this research. Because of this small element size, the B-scans 
can show better contrast between curved layers of different tissues, whereas 
larger transducers pick up backscatter signals and the curved interfaces reflect the 
excitation signal at different times (fig.6.15) 
                                      
Figure 6.15: Operation of ultrasonic transducers with different sizes  
(not to scale; small size transducer operates a single signal from a curved 
tissue interface, bigger size transducer picks up signals with different delays from 
the same interface, and backscatter signals) 
 
 
blood 
backscatter 
skin 
A-mode 
(3mm) 
A-mode 
(5mm) 
B-mode 
(5cm) 
reflection 
Ø 6mm 
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Fig.6.16 shows what happens when a transducer is placed against lumens of 
different shapes. For a rectangular lumen, the transducer position is irrelevant, 
but this shape is not found in the human body. In addition, the ultrasonic scans 
will be different if the tissue layers surrounding the artery are not perfectly 
concentrated around the centre of the lumen (fig.6.16, bottom). This is another 
reason why a B-mode transducer could be preferable, since many differently 
angled transducers could sense curved and uneven surfaces better. 
 
Figure 6.16: Ultrasound beam passing through flat (top), cylinder (middle) 
and uneven cylinder (bottom) surface 
 
After analysing the first set of results obtained from the 4.3 and 20 MHz 
transducers, it was concluded that it was better to use the 20MHz transducer with 
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the buffer. The settings for the UPR were changed from Setting 1 to Setting 2, as 
shown in fig 6.17, to increase the signal-to-noise ratio, by employing the 
excitation pulse of higher voltage (excitation voltages of over 70 V were not used 
in vivo).  
 Voltage (V) Gain (dB) 
Setting 1 30 56 
Setting 2 70 48 
Figure 6.17: Different settings for the UPR.  
Setting 2 was used for the following experiments. The recorded waveform is 
shown in fig.6.18. 
 
 
 
Figure 6.18: Three superimposed A-mode scans with the buffered 20MHz 
transducer, UPR Settings 2 (horizontal axis ± time LQȝVYHUWLFDO± recorded 
voltage in V) 
Mff Mbf Mfb Mbb 
ML1 ML2 MA2 MA1 
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In fig 6.18, the first two markers (MA1 and MA2 below the graph) were used to 
locate the possible position of the front wall (Mff and Mfb above the graph), 
taking it from the range presented in fig 6.11. Once the front wall was found, the 
position of the lumen (ML1 and ML2 below the graph) was assessed and marked 
from the range in fig.6.11. Finally, the back wall (Mbf and Mbb above the graph) 
was located. When the layers were isolated, their thicknesses were estimated at 
0.54mm, 5.725mm and 0.7875mm for the front wall IMT, the lumen and back 
wall IMT, respectively. A single record from fig.6.18 is presented in fig.6.19. 
 
Figure 6.19: A single A-mode scan for the 20MHz transducer with buffer and 
the UPR Setting 2 (horizontal axis ± WLPHLQȝVYHUWLFDO± recorded voltage in V) 
 
Another source of variability in recorded waveforms related to the pressure 
applied to the CCA during measurements. The diameter of a lumen decreases 
when the pressure applied to the CCA increases [6.7]. This will cause the lumen 
diameter to appear smaller than it really is. The first two markers (MA1 and MA2, 
Mff Mbf Mfb Mbb 
ML1 ML2 MA1 MA2 
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fig 6.19) were used to locate the possible position of the front wall (Mff and Mfb) 
from the range presented in fig 6.11. Once the front wall was found by this 
procedure, the position of the lumen was assessed and marked (ML1 and ML2) 
from the range presented in fig.6.11. Finally, the back wall (Mbf and Mbb) was 
marked. This change in the lumen diameter was observed experimentally when 
another A-scan was taken, with more pressure applied by hand through the 
transducer to the CCA (fig 6.20). 
 
 
Figure 6.20: A-mode scan for the buffered 20MHz transducer, the UPR Setting 2 
when a pressure was applied by hand to the CCA through the transducer 
(horizontal axis ± WLPHLQȝVYHUWLFDO± recorded voltage in V) 
 
Comparison of fig 6.20 with fig.6.19 shows the differences to the recorded A-
scans caused by the extra hand pressure applied to the transducer.
Mff Mbf Mfb Mbb 
ML1 ML2 MA1 MA2 
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6.4) Designing a new buffer for the 20 MHz transducer 
The main reason for using a buffer with an ultrasonic transducer is to avoid 
the dead zone in pulse-echo mode. The dead zone is a part of the object close to 
the transducer whose echoes cannot be seen on the received waveform due to 
interference of any unfinished transitions caused by excitation. The buffer 
provides a delay that ensures that echoes from the close parts of the body arrive 
after the end of any excitation transitions, and these echoes become visible on the 
received waveform. The drawback is that the echoes from the buffer-object 
interface reverberate in the buffer, masking echoes from more distant parts of the 
object. 
Fig.6.21 shows that these reverberating echoes masked the areas of interest 
on the waveform, and another buffer was designed to prevent this masking. 
 
Figure 6.21: An A-mode scan with a 20MHz transducer and shoe 
 
The new buffer was to provide a delay bigger than  
Ĳ Ĳ1 Ĳ2 Ĳ3 
Ĳ -11.17) + (20.63-15.85) + (25.43-20.63) 
Ĳ3 
 
Ĳ2 
 
Ĳ1 
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Ĳ  
Ĳ V 
 
The additional length for the new buffer can be calculated as : 
c
2 
  
u lW => 
2
cl u W => 
2
150026.14 u l  => mml 7.10  
 
The total length of the new buffer is: 
Lt = Lo + L 
(where Lt, Lo and L are the total length, original buffer length and additional 
buffer length respectively) 
Lt = 5.5 +10.7 = 16.2 mm 
 
In the formula 
c
2 
  
u lW , the factor 2 refers to the pulse-echo mode as the wave 
travels in the shoe, forwards and backwards.  
The dimensions for the new buffer are presented in the fig.6.22, and the 
drawings are shown in fig.6.23. 
 
 L1 
(mm) 
L2 
(mm) 
LT 
(mm) 
R1 
(mm) 
R2 
(mm) 
Present Buffer 1.3 4.2 5.5 4.7 6.3 
New Buffer 1.3 15 16.3 4.7 6.3 
Table 6.22: Table stating the specifications of the existing and new buffers 
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Figure 6.23: The existing and the new shoe 
 
The buffer was manufactured from polycarbon, since rexalite or another 
VXLWDEOH PDWHULDO >@ ZDV QRW DYDLODEOH IURP WKH VFKRRO¶V ZRUNVKRS 7KH
acoustic properties, such as attenuation and acoustic impedance of the 
polycarbon and rexalite, are compared in fig. 6.24. 
 
 Acoustic 
Impedance, MRayl 
Attenuation Coefficient 
(dB/cm) at 5MHz 
Polycarbon 2.7 24.9 
Rexalite 2.5 1.8 
Figure 6.24: Table showing acoustic properties of two buffer materials 
 
When ultrasound propagates through a boundary between two layers, the 
amount of ultrasound that can pass through and reflect from the boundary will 
depend on the acoustic impedances of both layers. The higher the mismatch 
between the acoustic impedances, the more energy is reflected back in the first 
layer and less energy propagates into the second layer. The recommended ratio of 
the acoustic impedances for the layers is below 5, but if the second layer is 
R2 
L1 
R1 
L2 
R2 
R1 
L2 
L1 LT 
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liquid, then the ratio should be below 3 [6.9]. From this point of view, the lower 
impedance of polycarbonate (fig.6.24) is preferable for the buffer. 
Attenuation describes the reduction of the amplitude of a wave while it 
travels through a medium. The attenuation coefficient takes the frequency of the 
wave and the distance travelled into account. Increases in any of these factors 
(frequency and distance) will lead to additional reduction in the wave amplitude. 
In this respect, polycarbonate is inferior to rexalite (fig.6.24). 
 
6.5) Scanning the CCA with the new buffer 
The parameters for the operation of the ultrasonic instrument with the new 
buffer were determined experimentally, as shown in fig 6.25. The parameters for 
WinUPR were set as presented in fig.6.17. 
 
Figure 6.25: Parameters for 20MHz transducer and new buffer 
 
The experimental waveform taken using the new buffer in vivo (fig 6.26) did 
not meet expectations, due to high losses in the buffer material. These losses 
masked reflections from distant tissues with noise. Therefore, the original buffer 
was used for subsequent scans. 
Sampling 
scheme 
ADC 
sampling 
frequency 
Number of 
averages 
First 
window 
delay(µs) 
First 
window 
duration(µs) 
Second 
window 
delay(µs) 
Second 
window 
duration(µs) 
4-5 100 128 6.2 2 18 20 
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Figure 6.26: A-mode scans with a 20MHz transducer and  
a new polycarbon shoe 
 
6.6) Considerations on use of automated gain control (AGC) to improve 
clarity of ultrasonic scans 
The analysis of ultrasonic scans is complicated because of a significant 
difference between amplitudes of echoes produced by close and distant objects. 
The amplitudes of echoes from distant objects could be several orders of 
magnitude lower and thus unrecognisable on the same waveform. The received 
signal can be attenuated by as much as 60dB compared to the ultrasonic signal 
being sent [6.10]. This can be addressed by using a method called AGC 
(Automated Gain Control) [6.11]. AGC usually increases the gain of the receiver 
amplifier with time (or, with distance travelled, which is the same) to compensate 
for extra attenuation experienced by ultrasonic waves to reach distant objects and 
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travel back. The gain is controlled by an automated system that sends different 
codes for different amplifications (fig 6.27). The amplifier provides non-linear 
increases in gain with time (fig 6.28). This results in an extra amplification for 
the signal from the back wall. 
 
 
 
 
 
 
Figure 6.27: Hardware for AGC                                Figure 6.28: A typical gain  
             versus time AGC curve 
 
For the AGC to be efficient and accurate, rather than just dependent on a 
quadratic function, a process called adaptive Time Gain Curves could be used 
[6.12]. The automatic gain control systems are usually implemented on the 
hardware side.  
The drawbacks of AGC include the need for re-design of the receiver 
amplifier as it needs to be controllable. There is also a need for the echo signal to 
exceed the noise level, otherwise the distant echoes still will be invisible because 
of noise masking and there will be possible distortions to shapes of echo signals 
because of continuous gain changes. Because of these shortcomings, the AGC 
was not implemented in this project. 
1 
Gain 
t 
Amp 
DAC Control 
Signal In Signal Out 
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6.7) Taking ECG triggered ultrasonic scans in vivo 
The complete setup is shown in fig.6.29 and included a personal computer 
with the Xtreme DSP FPGA board inside, the ECG monitor with a laptop to 
observe and record the ECG waveforms, and an oscilloscope to monitor the 
ultrasonic signals. 
 
Figure 6.29: Laboratory setup for taking in vivo ultrasonic scans  
 
The values of parameters of the ultrasonic instrument that were used for the 
experiments are presented in fig. 6.30. 
Sampling 
scheme 
ADC sampling 
frequency 
(MHz) 
Number of 
averages 
First 
window 
delay (µs) 
First window 
duration (µs) 
Second 
window 
delay (µs) 
Second 
window 
duration(µs) 
4-5 100 128 6.2 2 10 32 
Figure 6.30: Parameters of the ultrasonic instruments used for in vivo scans 
(20 MHz transducer with buffer) 
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The parameters set via WinUPR are presented in fig 6.31.  
Pulser Centre 
Frequency(MHz) 
Pulser 
Repetition Rate 
(kHz) 
Pulser 
Output Voltage 
(V) 
Output Gain 
(dB) 
20.1 1.0 100 49.5 
Figure 6.31: Parameters set for the UPR (20MHz transducer with buffer) 
 
The whole system was connected and tested, using the same subject as 
before. Six scans were taken; the first three scans triggered at one specific instant 
in the ECG, whereas the next three scans were triggered at another instant in the 
ECG signal. 
 
 
Figure 6.32: A-mode scan triggered at the S wave (20MHz transducer with   
Mff Mfb MA1 MA2 
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The first two markers are used to locate the possible position of the front 
wall, taking it from the range presented in fig 6.11 (fig 6.32). Once the front wall 
was found, the next step was to calculate the front wall IMT. For the first scan, 
the ECG was conditioned to trigger the ultrasonic scan at the S wave (fig 6.33). 
 
Figure 6.33: ECG waveform showing the trigger at the S-wave 
 
The distance between the two markers, Mff and Mfb, was estimated at about 
1.0 µs. As the ultrasonic instrument operated in the pulse echo mode, the 
ultrasonic wave first travelled to the reflector and then returned, covering the 
same distance. Therefore, the distance between the transducer and the reflector L 
is calculated using the following formula: 
 
 L = (wave velocity) * (time delay) / 2 
 
     = (1500m/s*1.0 µs) / 2   =  0.75 mm 
 
This value belongs to the range of the expected IMT values. 
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Figure 6.34: A-mode scan triggered at the U-wave (20MHz transducer with 
buffer) (horizontal axis ± WLPHLQȝVYHUWLFDO± recorded voltage in V) 
 
The other scan (fig.6.34) was taken at a different point of the cardiac cycle; 
namely, at the U wave (fig.6.35). 
 
Figure 6.35: Ultrasonic scan triggered at U-wave 
 
Mff Mfb MA1 MA2 
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The delay value between first two markers was estimated at 0.97 µs. 
Consequently the calculated IMT value in this case was different from the 
previous scan: 
 x= (1500m/s*0.97 µs) / 2  =  0.73 mm. 
 
Therefore, the IMT estimates obtained for two ultrasonic scans triggered at 
different points of the cardiac cycle showed a difference of about 20 µm. The 
front wall IMT is known to vary up to 80µm within a single cardiac cycle, 
depending on the patient [6.13]. Therefore, the obtained difference agrees with 
the published data; the designed instrument did not produce evidently erroneous 
experimental results. 
 
6.8) Cardiovascular Disease Risk Assessment Protocol 
By looking at the results that are presented in this chapter, the conclusion can 
be drawn that the hardware worked and it could accurately record the ultrasonic 
scans triggered in vivo by the ECG monitor in the subject.  
A further study was required to comply with medical standards that would 
involve many patients. The results obtained with the developed instruments were 
to be checked against the results obtained with conventional instrumentation.  
As discussed in chapter 1, while guidelines for detection of silent myocardial 
and lower limb ischemia are established, data on screening asymptomatic carotid 
lesions in diabetic patients remain scarce. In diabetic patients, Carotid IMT was 
recognized as a reliable prognostic indicator of heart attack and stroke. It worsens 
P a g e  | 165 
with duration of diabetes and association with other risks. Diabetic patients carry 
an increased risk of ischemic cerebral attack and this risk is two to five times 
higher than that for the general population.  
There are many ways to evaluate cardiovascular disease risk to the patient. 
Before doing an ultrasound scan to measure the IMT, it is always useful to do a 
cardiovascular disease risk assessment report, since there are many factors that 
affect the progression of the disease. This report can be used as a reference, 
together with the scan, to diagnose correct symptoms. The protocol (fig 6.36) 
should be efficient in identifying CVDs and not overly time consuming. 
 
 
Figure 6.36: Diagram showing the steps that would be taken  
for the CVD protocol 
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6.8.1) Questionnaire 
A questionnaire form will be given to the patients if it is their first time to 
have an ultrasonic scan for evaluation of the CVD risk. The questionnaire form 
will include hospital details of the patient and some personal information 
affecting the IMT such as age, sex, ethnicity and some others factors too. The 
final section of the questionnaire will include an agreement that the medical data 
are to be used for analysis only. It is important that the patient answers the 
questions accurately, since the data will be used in reporting and interpretation. 
 
6.8.2) Ultrasonic scan 
After filling in the questionnaire form, the patient will be sent to have an 
ultrasound scan. In order to perform the scans, the proposed machine will be used 
to measure the IMT of the CCA. This differs from conventional B-scans in that a 
single element transducer will be used rather than a linear array transducer. The 
developed instrument will use a single element transducer with a higher 
frequency and a removable buffer (commonly called a ³VKRH´ LQ WKH ILHOG RI
ultrasonic NDE) to produce at least the same or even better images compared to 
those acquired using the linear array transducers. 
The sonographer performing the scan will give the patient some information 
on what will be done. The patient has to be in the supine position with the neck 
rotated away from the probe so that longitudinal images of the three different 
positions (anterior, lateral and posterior)can be taken for the IMT measurement. 
These three positions are angled at around 45 degrees to each other, and can be 
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determined by using a Meijer arc. It is first necessary to find the point where the 
CCA splits into the internal and external carotid arteries. Scanning is preferable 
of the right CCA (RCCA) but it is better to take scans of both the RCCA and the 
LCCA (left CCA) in order to have extra data. The point of taking the ultrasonic 
VFDQUHODWHGWRWKHSDWLHQW¶VFDUGLDFF\FOHFDQEHPRGLILHGE\WKHVRQRJUDSKHUE\
changing the delay after the R wave, if necessary.  
 
6.8.3) Data reporting 
Once the ultrasonic instrument is triggered to take the scan, it will save these 
scans into the computer, where the scans will be analysed. To assure that the 
measurement is obtained accurately, both the near and the far wall will be 
considered using computer assisted tracing if applicable.  
When the boundaries of the blood-intima and the media-adventitia are not 
very clear, a less accurate value of the IMT is measured. Allowing the user to 
change the boundaries detected by the computer-assisted tracing will be useful in 
areas where it is not possible to find the correct boundary exactly. The results of 
each view should be reported, taking into account that they should be within 0.05 
mm of each other. Additionally, the mean value should be reported. The 
maximum value of each side will be useful for identifying the CVD risk at that 
point. Once all of the necessary measurements have been taken, they will be 
forwarded to a doctor for further analysis and recommendation. 
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6.8.4) Interpretation 
After the IMT scan, the patient will have another appointment with the 
specialist doctor to interpret the results. The questionnaire form that was filled in 
before doing the scan is vital at this point, since it will be used to relate any past 
patient or family history to the values obtained. The results can be compared with 
the results obtained in the conventional way, but it is more accurate to state the 
IMT results in percentiles rather than just numerical values. This will make 
assessment of the progression of the artery easier.  
The principal percentiles will be 25th and 75th percentiles and the percentiles 
in between. The reason for using two percentiles and values between them is that 
any value below 25th percentile would show that there is some increase, but this 
increase is not of a high risk. The values between the 25th and 75th percentiles 
will show that there is not much CVD risk. However, actions could be taken to 
prevent further increase if necessary. Finally, the IMT values above 75th 
percentile would be taken as a very high risk of CVD, since it has increased to a 
level where the CCA is nearly completely blocked out. 
 
6.8.5) Recommendations 
Depending on the results obtained from the ultrasound scan, recommendation 
for further actions will be given based on the values mentioned above. At the 
same time, further actions can be recommended, such as diet changes and 
exercising, and the patient could be introduced to some therapeutic and chemical 
treatments, such as prescribing aspirin or vitamin E tablets, if necessary. All of 
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the patients that have an IMT value greater than 75th percentile will be at high 
risk and should be treated urgently to reduce this value as much as possible, in 
order to prevent surgery and intense treatment required otherwise. At this stage, 
stenting and chemical treatment are usually preferred. A later ultrasonic scan, as 
a check-up to observe further IMT changes, may be recommended for all of the 
screened patients. 
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Chapter 7 - Discussion and Conclusions 
 
The main aim of the project was to build a system where the vascular 
ultrasonic scans are synchronised with the heart activity using the ECG signal. 
The project involved diverse areas of medicine and engineering. The medicine 
side included cardiovascular, cardiology and radiology, whereas the engineering 
side was more related to hardware and software developments. The following 
activities were undertaken: 
x researching and visiting a hospital to get more knowledge about the 
medical side, to aid the decision making throughout the project; 
x  simulating circuits with LTSpice and comparing the results to real 
measurements; 
x designing PCBs and circuit components using EAGLE; 
x designing support hardware and firmware for PIC microcontrollers; 
x understanding how the existing FPGA design worked and designing a 
modified version that could be triggered from the ECG monitor; 
x  using Matlab in many areas of the project either to capture or analyse the 
data ; 
x  prototyping electronic circuits using various means; 
x understanding operation, control and use of ultrasonic instruments and 
transducers. 
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The above list shows the key points of the whole project. The findings that 
were discovered throughout the project are summarized and brief conclusions on 
each are given in this chapter.  
First of all, the different topologies of ECG circuits were reviewed at the 
beginning of the second chapter. Each topology had some advantages and 
disadvantages in terms of circuitry, safety, filtering and amplification. The 
simulation program, LTSpice, was used for each of the candidate amplifiers, but 
the simulated noise level, gain and ac analysis were not found with the desired 
precision. Therefore, the circuits in question were prototyped. The instrumental 
amplifier from Texas Instrument (INA326) performed much better over the other 
candidate amplifiers, and its single voltage power supply gave additional 
advantages. It was therefore selected for the ECG monitor. 
Detailed design of the ECG monitor was described in chapter 3. Significant 
work went into the design of the PCB. The required components, which did not 
exist in the software library, were created. The error rule checks were done on 
the whole device to verify that the design was compatible with the manufacturing 
house technology. The change of the degree program, due to personal 
circumstances, forced the necessity of a design of a different front end. The 
proposed front end consisted of an instrumental amplifier, an active low pass 
filter, and regulators. It included various connections for programming or 
detecting or triggering such as RS-232, BNC and ICD, and microcontroller 
sockets. A +5V transceiver was used between the front end and the RS-232 
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socket to provide the required communication voltages. The completed front end 
was tested and performed as expected.  
Wireless ECG signal transmission was the preferred choice in this project, 
due to safety considerations and because the mobility of the patient would not be 
restricted. After the occurrence of personal problems, another possibility was 
considered. However, the microcontroller program for the wireless transfer was 
written and discussed in chapter 4. Its testing showed that the rfPIC 
microcontroller had its debug limitations and an additional module was 
developed to ease debugging. The experimental results of both microcontrollers 
were compared. This completed the design of the front end of the system. 
The next task was to understand the operation of the existing ultrasonic 
system and to modify it to suit the developed application. The existing system is 
described in chapter 5, and the design that was initially considered was applied, 
but was not successful. Once the problem was identified, an alternative design 
was applied to the existing system. The validity of the change in the GUI for the 
front end to start the triggering was verified with an additional trigger veroboard, 
which sent out triggering signals to the ADC on the FPGA board. 
The different ways of locating the CCA were reviewed at the beginning of 
chapter 6. The simplest way of finding it was chosen, out of several options 
available. For the ultrasound scans, the main challenge comes from the 
optimization and tradeoffs between noise, gain and visibility. For example, the 
pulser output voltage and the amplifier gain have different effects on these 
factors. The number of averages, the sampling scheme a
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rate affected the noise level and signal visibility level. A significant number of 
ultrasonic scans taken using various parameters was analysed to aid in 
understanding and processing. Use of a buffer with the ultrasonic transducer 
resulted in much more consistent echoes from the CCA. In order to aid further 
signal enhancement, a new buffer for the existing 20 MHz transducer was 
created. This buffer was found unsatisfactory though because of high signal 
losses. 
From all of the ultrasonic scans examined, the back wall of the artery was not 
easy to distinguish because of the small amplitude of its echo signal. Regardless 
of the presence or absence of a transducer buffer, the visibility of the back wall 
was not sufficient in any of the cases. Therefore, the old buffer with the 
transducer was used to look for the front wall of the CCA. The ultrasonic scans 
were triggered at different phases of the cardiac cycle by setting different delays 
to the trigger after the R wave peak. The estimated IMT values were found to be 
different, and the difference was within the range expected from the literature. 
Therefore, in vivo experiments did not give evidently erroneous results.  
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Chapter 8 - Future work 
 
Although the required operation of the instrument was achieved, there are 
possibilities for its further development. First, the electronics developed could be 
assembled using a dedicated PCB, and the size of the whole board would 
decrease by more than 50%. At present, the signal to trigger the ultrasound 
instrument is supplied via a coaxial cable. If a wireless system were employed to 
send these data wirelessly, this would increase mobility and safety of the patient. 
Possible RF interference can be overcome by careful design and by using 
wireless communications other than RF, e.g., infrared.  
As discussed in the previous chapter, the back wall of the CCA could not be 
identified as easily as the front wall, due to the ultrasound attenuation. By 
applying the AGC (Automated Gain Control) to the received signal, it is possible 
to compensate for this extra attenuation and to enhance the back echo. This will 
improve the presentation of the echo, but will not improve its SNR. 
 Another improvement could be extension of ECG triggering to ultrasonic B-
scans. In this case, a transducer array will be required and collection of many 
echoes requires many excitations. On the positive side, B-scan images allow for 
easier detection of front and back walls compared to A-scans. Finally, when the 
above refinements are completed, the instrument can be tested in a hospital, 
using the CVD protocol described in the last part of chapter 6.  
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Chapter 9 - Appendix 
 
Appendix A: Questionnaire form being sent to the specialist in cardiology 
department to get more information about ECG 
 
 
 
 
 
Omer Faruk Bener 
School of Electrical and Electronic Engineering, 
University of Nottingham, 
University Park, 
Nottingham, 
NG7 2RD 
UK 
Email: eexofb@nottingham.ac.uk 
Mob: +447818241464 
Tel: +441158451146 
 
11 October 2007 
 
Dr. Wafer Dabdoub 
Department of Cardiology 
Hamad Medical Corporation, 
P.O. Box 3050, 
Doha, Qatar 
Email: wdabdoob@yahoo.com 
Mob: +974 536 9902 
Fax: +974 439 2454 
 
Subject: Questionnaire Form ± Information about ECG related to IMT  
 
Dear Dr. Wafer Dabdoub, 
 
With reference to above subject, this letter is to learn more about the ECG. 
There are a few questions that was come across while designing the new ECG 
machine that will be used inter linked with the ultrasound machine to take IMT 
scans. If you could kindly fill out the questions below and return it to me. This 
will be really helpful in evaluating the right solution for the ECG machine. 
 
- Do you know the manufacturer and model of the electrode pads and 
machine being used when taking the ECG of the patient? 
 
- How many electrode pads are used when taking an ECG and what is each 
one used for? Would it make accurate if more are added? 
P a g e  | 179 
 
- Are the pads being used for taking the ECG of the patient disposable or 
reusable pads? If it is reusable then what are the procedures to apply to the pads 
before use for another patient? Also how many ECG tests can be read with a 
single ECG pad set? 
 
- There are different waves P, Q, R, S, T, which wave would be the best when 
looking at the ECG when wanting to obtain the best result for IMT? If so why 
this choice? Could you specify any particular part of this wave? Does the device 
on the age/sex etc? 
 
Should you have any queries and questions, which I failed to address, please 
do not hesitate to contact me at any time. Looking forward to hearing from you. 
Thanking you in anticipation. Kindest Regards. 
 
Yours Sincerely 
 
Omer Faruk Bener 
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Appendix B: Schematic of the 4TH order Bessel 20Hz Low Pass Filter created using FilterLab 
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Appendix C: Schematic of the 4TH order Bessel 40Hz Low Pass Filter created using FilterLab 
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Appendix D: Schematic of the front end which will be used to design the PCB 
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Appendix E: Error Rule Check Report for the schematic design for the front end 
 
EAGLE Version 4.16r2 Copyright (c) 1988-2006 CadSoft 
 
Electrical Rule Check for C:/vero/ecg4.sch at 01/10/2008 21:20:36  
 
WARNING: Sheet 1/1: unconnected Pin: U$9 INPUT1_1 
WARNING: Sheet 1/1: unconnected Pin: U$10 INPUT1_1 
WARNING: Sheet 1/1: unconnected Pin: U$11 INPUT1_1 
WARNING: Sheet 1/1: unconnected Pin: U$12 INPUT1_1 
WARNING: Sheet 1/1: unconnected Pin: U$13 INPUT1_1 
WARNING: Sheet 1/1: unconnected Pin: U$14 INPUT1_1 
WARNING: Sheet 1/1: POWER Pin IC1 VDDRF connected to N$33 
WARNING: Sheet 1/1: POWER Pin IC1 VSS connected to GND 
ERROR: Sheet 1/1: unconnected INPUT Pin: IC1 DATA_FSK 
WARNING: Sheet 1/1: POWER Pin IC1 VSSRF connected to GND 
WARNING: Sheet 1/1: POWER Pin IC1 VDD connected to N$33 
WARNING: Sheet 1/1: POWER Pin IC1 VSSRF2 connected to GND 
Board and schematic are consistent 
 
    1 errors 
   11 warnings 
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Appendix F: Schematic of the front end which will be used to design the veroboard 
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Appendix G: Glossary  
(taken form http://medical-dictionary.thefreedictionary.com ) 
 
Attenuation is the reduction in amplitude and intensity of a signal. Signals may 
attenuate exponentially by transmission through a medium, in which case 
attenuation is usually reported in dB with respect to distance travelled through 
the medium. Attenuation can also be understood to be the opposite of 
amplification. Attenuation is an important property in telecommunications and 
ultrasound applications because of its importance in determining signal strength 
as a function of distance. Attenuation is usually measured in units of decibels per 
unit length of medium (dB/cm, dB/km, etc) and is represented by the attenuation 
coefficient of the medium in question.  
 
Attenuation coefficients are used to quantify different media according to how 
strongly the transmitted ultrasound amplitude decreases as a function of 
frequency. The attenuation coefficient (Į) can be used to determine total 
attenuation in dB/cm in the medium using the following formula: 
 
As this equation shows, in addition to the medium length and attenuation 
coefficient, attenuation is also linearly dependent on the frequency of the 
incident ultrasound beam. Attenuation coefficients vary widely for different 
media. In biomedical ultrasound imaging however, biological materials and 
water are the most commonly used media. The attenuation coefficients of 
common biological materials at a frequency of 1 MHz are listed below: 
Material ĮG%0+]FP 
Lung 41 
Bone 20 
Kidney 1.0 
Liver 0.94 
Fat 0.63 
Blood 0.18 
Brain 0.85 
Water 0.0022 
Acoustic energy losses occur in two general ways: absorption and scattering. 
Ultrasound propagation through homogeneous media is associated only with 
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absorption and can be characterised with absorption coefficient only. Propagation 
through heterogeneous media requires taking into account scattering. 
 
Acoustic impedance,  
Interference with the passage of sound waves by objects in the path of those 
waves. It equals the velocity of sound in a medium multiplied by the density of 
the medium. The acoustic impedance of bone may be nearly five times as great 
as that of blood. 
 
Axial resolution,  
The ability of an ultrasound system to separate two objects lying along the axis 
of an ultrasound beam.  
 
 
Beam diameter (beam width) 
(although the article uses electromagnetic waves for discussion, the same 
statements apply to ultrasound waves)  
The diameter along any specified line perpendicular to an electromagnetic beam 
axis and intersects it. Since beams typically do not have sharp edges, the 
diameter can be obtained in many different ways. Five definitions of the beam 
width are in comPRQ XVH 'ı  RU  NQLIH-edge, 1/e2, FWHM, and 
D86. 
Beam diameter usually refers to a beam of circular cross section, but not 
necessarily so. A beam may, for example, have an elliptical cross section, in 
which case the orientation of the beam diameter must be specified, for example 
with respect to the major or minor axis of the elliptical cross section. The term 
"beam width" may be preferred in applications where the beam does not have 
circular symmetry. 
 
 
Beam divergence 
(although the article uses electromagnetic waves for discussion, the same 
statements apply to ultrasound waves)  
An angular measure of the increase in beam diameter, with distance from the 
optical aperture or antenna aperture, from which the electromagnetic beam 
emerges. The term is relevant only in the "far field", away from any focus of the 
beam. Practically speaking, however, the far field can commence physically 
close to the radiating aperture, depending on aperture diameter and the operating 
wavelength. 
Beam divergence is often used to characterize electromagnetic beams in the 
optical regime, for cases in which the aperture from which the beam emerges is 
very large with respect to the wavelength. That said, it is also used in the Radio 
Frequency (RF) regime for cases in which the antenna is operating in the so-
called optical region and is likewise very large relative to a wavelength. 
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Lateral resolution  
The resolution of objects in a plane perpendicular to the axis of an ultrasound 
beam. It is a measure of the ability of the system to detect closely separated 
objects, such as adjacent blood vessels.  
 
 
Penetration depth  
(although the article uses electromagnetic waves for discussion, the same 
statements apply to ultrasound waves)  
A measure of how deep light or any electromagnetic radiation can penetrate into 
a material. It is defined as the depth at which the intensity of the radiation inside 
the material falls to 1/e (about 37%) of the original value at the surface. When 
electromagnetic radiation is incident on the surface of a material, part of it is 
reflected and part transmitted into the material. This EM Wave interacts with the 
atoms and electrons inside the material. Depending on the nature of the material, 
the EM Wave might travel very far into the material, or on the other hand die out 
very quickly. For a given material, penetration depth can vary for different 
wavelength of EM Wave, and usually, is not a fixed constant. 
 
 
Reflection and transmission coefficients 
Coefficients used in physics and electrical engineering when wave propagation in 
a medium containing discontinuities is considered.  A reflection coefficient 
describes either the amplitude or the intensity of a reflected wave relative to an 
incident wave.  A transmission coefficient describes either the amplitude or the 
intensity of a transmitted wave relative to an incident wave.  Different specialties 
have different applications for the term. (quantitative formulae and demos are 
available from 
 http://paws.kettering.edu/~drussell/Demos/reflect/reflect.html ) 
 
 
Tables of ultrasonic data: 
Ultrasound physics http://www.drgdiaz.com/tables.shtml 
Acoustic properties of common materials http://www.advanced-
ndt.co.uk/Velocity_Chart.html  
 
